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This work involves the investigation of a group of uniform materials based on 
organic salts (GUMBOS) as matrices for matrix assisted laser desorption ionization time 
of flight mass spectrometry (MALDI-TOF) for analysis of hydrophobic biomolecules. 
GUMBOS are new class of materials that show great promise as MALDI matrices 
because they are able to form a thin-layer on the MS target, thereby enhancing the sample 
homogeneity, signal intensity, and shot-to-shot reproducibility. The detection of 
hydrophobic peptides using MALDI-TOF MS remains a challenge because the majority 
of matrices utilized are hydrophilic thereby exhibiting low affinity for hydrophobic 
molecules. To address this, I have developed novel matrices of varying hydrophobicity 
based on aminopyrine (AP) to enhance the detection of such molecules. In the first part of 
this work, I outline the synthesis of a series of AP-based GUMBOS in which various 
counter-ions such as chloride, ascorbate, and bis(trifluoromethane) sulfonamide were 
used to tune the hydrophobicity of a matrix. The hydrophobicities of these compounds 
relative to α-cyano-4-hydroxycinnamic acid (CHCA), a common MALDI matrix, 
indicated that the AP-based GUMBOS can be tuned to greater hydrophobicity than 
CHCA. In addition, a clear trend was observed between the signal intensity of the 
hydrophobic peptides and the hydrophobicity of the matrix. In the second part of this 
work, I present a unique approach for predicting matrix-analyte interactions in MALDI 
using fluorescence spectroscopy. Interactions of analytes with matrices that are composed 
of AP and AP-based GUMBOS were investigated using a hydrophobic (gramicidin) and 




were used to investigate the interaction between matrices and peptides. Hydrophobic AP 
and AP-based GUMBOS revealed stronger interactions with hydrophobic peptides and 
enhanced detection of these peptides, which correlate well with the MALDI MS results. 
Finally, I have synthesized a hydrophobic GUMBOS-based matrix using CHCA and 
oleylamine (OA). The [OA][CHCA] GUMBOS was used as a matrix for MALDI MS for 
the detection of lipids in tissues and compared with 2,5-dihydroxybenzoic acid (DHB) 
had better signal reproducibility and improved homogeneity. These enhancements were 








CHAPTER 1: THE EVALUATION OF MASS SPECTROMETRY AND THE 
POTENTIAL OF IONIC LIQUIDS FOR MALDI MATRECES 
1.1  Mass Spectrometry  
Mass spectrometry (MS) is an important tool for the analysis of complex samples 
such as biomolecules, tissues, cell cultures, and polymers.[1] Recently in the MS field, 
imaging mass spectrometry (IMS) has emerged as technique for screening analytes such 
as lipids, peptides, proteins, and drugs.[2-8] Over the years, MS has become a powerful, 
and highly selective analytical tool used to evaluate the mass composition of a sample by 
separating the ions based on their mass-to-charge ratio (m/z).[9, 10] The two most recently, 
developed ionization methods in MS are electrospray ionization (ESI)[11] and matrix-
assisted laser desorption/ionization time of flight mass spectrometry (MALDI-TOF 
MS).[12] MALDI is a soft ionization technique, in which the gas phase ions are formed 
without fragmentation.[13] This technique has been extensively utilized to analyze of the 
wide range of biomolecules. This technique is particularly useful for characterizing the 
large thermally labile biomolecules and has recently found applications in imaging and 
clinical research.[1] The advantages of this approach include robustness, high throughput, 
high sensitivity and applicability to a wide range of compounds.  
A mass spectrometer (MS) is composed of three components:  ionization source, 
mass analyzer, and detector. A schematic of a mass spectrometer is shown in Figure 1.1. 
An inlet is used to transfer samples from atmospheric pressure into the ion source 
chamber where the analytes are converted into gaseous ions. Once the ions reach the 




charge ratio and transported under a magnetic field. The separated chemical ions are then 
detected and the produced signals are transferred to data analysis.[14] 
 
 
Figure 1.1. Schematic of a mass spectrometry of basic components. 
1.2 Matrix Assisted Laser Desorption Ionization Time of Flight Mass 
Spectrometry (MALDI-TOF MS)  
 
MALDI-TOF MS has evolved as an excellent tool for rapid, sensitive (femtomole 
or attomole), and accurate mass identification [1, 15, 16] and characterization of analytes.[17] 
This technique has the ability to detect low molecular weight compounds of peptides or 
amino acids.[18, 19] In 1988, Karas and Hillenkamp[12] demonstrated that MALDI-TOF-
MS  provide the advantage of rapid and accurate identification and characterization of 
such analytes with minimal sample introduction.  Since its development, MALDI-TOF 
MS has been increasingly used in the biological sciences particularly for the 














The development of MALDI was influenced by laser desorption ionization (LDI), 
which is used to ionize compounds less than 1000 Da.[14] Though, LDI has been 
previously used for the ionization of highly volatile molecules.[14] Though, LDI has been 
previously used for the ionization of highly volatile molecules, it is difficult to control 
excessive thermal degradation and some compounds are unable to absorb laser irradiation 
in LDI.[21]  
1.2.1 Operational Mode of MALD IMS 
The operation of MALDI-MS involves three steps. The first step involves the use 
of a matrix that in the MALDI mechanism will donate a proton to the analyte. During this 
first step, the matrix and analyte are mixed and then spotted on target and left at room 
temperature until the solvent evaporated. Once the solvent is vaporized, a uniform co-
crystal of the matrix and analyte that depends on the type of matrix, surface, evaporation, 
etc., is generated. Typically, the analyte and matrix are prepared at a molar ratio of 
1:1000 and 1:10,000 for the analysis of peptides and proteins, respectively.[22] Next, the 
crystalline mixture is irradiated with a laser pulse from sources such as 337 nm nitrogen 
laser or 355 nm Nd:YAG laser. The matrix absorbs energy and transfers protons to the 
analyte.[23] This energy is used for desorption and ionization of the analyte which is 
subsequently focused towards the mass analyzer. Upon ionization, analytes are 
accelerated using high voltage and then separated under high vacuum.[24] Such separation 
is achieved based on the mass-to-charge ratio of the ions. A schematic of the MALDI-MS 







Figure 1.2. Schematic diagram of the matrix and analytes co-crystallized on the MALDI 
target followed by irradiation with a laser pulse. The matrix absorbs the energy from the 
laser then transfers the proton to the analyte. Protonation occurs by transferring protons to 
the analyte via gas-phase collisions or cluster ionization. M represents matrix and A 
represents analyte.  
	  
1.2.2 Time of Flight Mass Spectrometry (TOFMS)  
While this MALDI ionization technique can be coupled with various mass 
analyzers such as Time of Flight (TOF), Fourier Transform Mass Spectrometry (FTMS), 
Quadruple Time of Flight (QTOF), etc., this research will focus on applications with 
TOF. Time of Flight (TOF) measurement is an analytical technique that is used to 
analyze the mass of a sample. The TOF based technique was developed by Cameron has 
been further improved for higher mass resolution and sensitivity through the use of time-
lag focusing techniques. [25, 26] Today TOF is frequently used with MALDI MS and it is 
employed in either reflectron or linear mode, which will be described later.   
TOF mass spectrometry has many advantages over other instruments such as high ion 
transmission, low cost, and theoretically unlimited mass (more than 100 kDa). The entire 




current, which makes TOF a fast technique, taking only a few microseconds.[27-30] A 
major advantage of TOF MS[30] is the entire mass spectrum can be recorded. Moreover, 
this approach has good transmission of ions and fast repetition rate. [2, 26] 
The TOF technique allows determination of the m/z ratio of the ions by measuring 
the flight time of ions in a field free region. The construction and operation of TOF is 
simple, which consists of an acceleration region, field free drift region, and a detector all 
housed inside a chamber.[31] The ions move from the ion source into the flight tube where 
they are accelerated by an electric field. When the ions reach the field free drift region, 
the acceleration gives all ions the same kinetic energy (KE) if they have the same charge. 




       (1)  
where KE represents the kinetic energy of the ions, which is determined by acceleration 
voltage, m is the mass of ions, and v is the velocity. Heavier ions reach the detector later 
than lighter ions. The mass-to-charge ratio (m/z) can be calculated based on the time it 
takes for ions in the field-free flight to reach the detector at the end of the tube.[31, 32] Ions 
with different mass to charge ratios that are accelerated into the field free drift region will 
have different velocities. Based on this concept, the KE of the ions can be calculated 





where !  is mass, z is the charge, and v is velocity. Equations 1 and 2 can be rearranged 









where L is the length of the flight path and t is the time it takes the ion to travel a 
particular distance.[33] 
             Linear and reflectron are two types of TOF MS. Figure 1.3 shows a schematic of 
the linear mode TOF MS. In this method, the ions enter the field-free flight tube by 
acceleration and continue to move inside the flight tube until they hit the detector. Ions 
with different m/z, will have different velocities, thus travel inside the field-free region at 
different speeds.[34] Notably, ions that have similar (m/z), but have different velocities and 
initial positions, can reach the detector at different times. These factors directly affect the 
resolution of the linear TOF because even if the ions have the same m/z ratio, they do not 
necessarily reach the detector at the same time. For these reasons, the linear mode has a 
lower resolution. [35].  





     (4) 
where m is the observed mass and !" is the difference in the mass error of ions, ! is the 
flight time and Δt is difference in times at the full width at half maximum (FWHM) of a 
peak. Mass accuracy is defined as the difference between the exact mass and the 
observed mass. Mass accuracy can be calculated in part per million (ppm).  
 Mass Accuracy = 106× (Mm - Mt) 
Mt
     (5) 
 
 







Figure 1.3. Schematic of mass separation by linear-TOF mass analyzer. The lighter ions 
reach the detector sooner than heavy ions with the same charge. 
 
Linear mode TOF exhibits low mass resolution (~1000),[36] which affects mass 
accuracy. When using linear mode, the isotopic distribution of ions cannot be 
distinguished. Mass accuracy with high resolution is important for complex samples such 
as tissues. In order to solve this problem, TOF in ion reflectron mode can be used. 
Reflectron mode TOF can easily obtain a mass with resolution greater than 
10,000.[30]This mode has good resolution due to the addition of an ion mirror at the end of 
the flight tube region.[32] Figure 1.4 shows a reflectron TOF mass analyzer that is used to 
maximize the resolution for ions with the same mass to charge ratio. Some ions can have 
higher velocity and the others have lower velocity due to same mass. The ions with a 
higher energy not only travel faster but also penetrate deeper and spend more time in the 
ion mirror [33] On the other hand, ions with lower velocity do not penetrate as deeply as a 
result they spend less time in the ion mirror. When the detector position is adjusted 




time. Additionally, resolution can be improved by increasing the path length of the 
reflectron (L1+L2). All ions that have the same (m/z) ratio will reach the detector, located 
at the end of flight path L2.
[35] 
 
Figure 1.4. Schematic of the reflectron-TOF mass analyzer. All the m/z ions have 
different kinetic energy. They arrive at the same time at the detector that is located at the 
end of path flight L2. 
	  
  
Another method used to improve resolution is delayed ion extraction.[37, 38]  In this 
method, ions are extracted from an ion source after laser irradiation of the sample. This 
occurs after a short time delay, on the order of one hundred nanoseconds. If an ion has a 
lower velocity, it is accelerated more when the extraction potential is applied. 
Conversely, the ions with a high velocity are accelerated less when the extraction 
























1.2.3  Matrix Ionization  
Although MALDI has been used for decades, the exact mechanism of ionization 
is still being debated.[39] Matrix ionization occurs in two steps; the first is called primary 
ionization, in which a laser is used to irradiate the matrix; the second is called secondary 
ionization, which happens in the gas phase to form a plume on the top of the target as 
shown in Figure 1.2. In primary ionization, the matrix (M) absorbs a photon from laser 
irradiation leading to an excited (M*).[40] The matrix transfers the proton to the analyte 
species in the laser-induced plume during the secondary ionization when the matrix and 
analyte collide.[40-42]  
An alternative mechanism forms ions in clusters. In this method, clusters are 
assumed to be formed in the desorption plume by trapping the numerous charged ions 
and counter ions that are derived from the analyte. The charges separated in the clusters 
have a deficit. The ions of analyte are formed by evaporation from the matrix, which has 
rich clusters.[43] 
1.2.4  Sample Preparation  
There are several important factors that affect the signal intensity in a MALDI 
mass spectrum.[44] One of these factors is sample preparation, more specifically, the co-
crystallization of analyte and matrix.[45] The homogeneity of a sample plays a role in the 
reproducibility and signal intensity of ion yields. Several techniques have been used to 
improve sample preparation. One of which is the dried-droplet technique,[46] in this 
method, 1 µL of the matrix and sample is respectively spotted  onto the target, mixed and 
dried slowly under ambient air.[46] Another method used to improve homogeneity is the 




solvent such as acetone with the analyte prepared in water. A few microliters of the 
matrix is spotted on the target then left until the solvent is evaporated and a film 
generated. Next, a few microliters of analyte is dropped on the target and the solvent is 
dried slowly under room temperature. The sandwich method is yet another technique 
used to improve homogeneity.[47] A few microliters of a matrix is deposited until a thin 
layer of the matrix is formed. Then the analyte is deposited upon the matrix. Finally, an 
additional layer of matrix is applied; thereafter, the mixture is then dried in ambient air.  
Electrospray method[48, 49] is also occasionally used to generate more homogenous 
samples. Briefly, the analyte and matrix solutions pass through a capillary at high 
potential and are deposited on the target plate to yield much smaller crystals and dried 
under a stream of nitrogen gas. Parameters such as flow rate and applied voltage can be 
controlled to optimize the method.  
Prior to the use of MALDI, calibration with a suitable reference (standard) 
compound(s) should be performed. For example, specifically for the Bruker instrument 
used for these studies a peptide standard, which contains seven standard peptides, can be 
used. Angiotensin II, angiotensin I, substance P, ACTH clip 1-17, ACTH 18-39 and 
Somalostain 28 are few examples of the peptides that can be used for calibration. To 
ensure high resolution and reproducibility, standards of highest purity must be used for 






Figure 1.5. 1 µL each from Peptide calibration standard and CHCA dried droplet mixed 
on plate target. 
 
1.3 MALDI Matrices  
In general, typical MALDI matrices must possess some specific properties that 
include: strong absorption at the wavelength laser,[50] and the ability to effectively 
disperse analytes.[51] Synthesized matrices must have the ability to be dissolved in the 
same solvent that is used for analytes. Moreover, matrices should also serve as good 
protonating or deprotonating agents. [23, 52, 53] 
1.3.1  Organic Matrices 
A variety of organic compounds can be used to prepare solid matrices. There are 
several characteristics that are required to make a good matrix. First, the material must 
strongly absorb at the same wavelength of the laser, 337 or 355 nm. They must dissolve 




the analyte, and be inert to reaction with analytes. Finally, they must have the capacity to 
crystallize and have a low heat of sublimation. [44]     
Solid matrices such as α-cyano-4-hydroxycinnamic acid (CHCA) have been used 
for the analysis of proteins and peptides with molecular weights below 10 kDa, while 2,5-
dihydroxbenzoic acid (DHB) and sinapinic acid (SA) have been used for the analysis of 
proteins with higher molecular weights.[54-56] Table 1.1 shows the structures and 
biological applications of commonly used matrices.  
A notable challenge in the quantification of analytes using MALDI is the poor sample-to-
sample and shot-to-shot reproducibility due to the formation of several sweet spots as a 
result of non-homogenous distribution of the matrix and analyte on the target.[51, 57-60] The 
extent of inhomogeneity depends on the type of matrix employed and deposition.[61] The 
non-homogeneous distribution of analytes increases the measurement time because 
analytes can be detected only in such spots. Therefore, in order to improve 
reproducibility, the selection of a suitable matrix that can produce homogeneous MALDI 
spots is important. [54] 
One method of increasing the homogeneity of these MALDI spots involves the 
use of nitrocellulose substrates.  The increased homogeneity that this method provides 
improved spot-to-spot reproducibility and the higher precision of peptides quantitation of 
MALDI.  Nitrocellulose substrates help to increase the uniformity of analyte distribution 
on the sample surface and increase interaction and binding between the analyte and 
matrix. Another advantage of using nitrocellulose is the reduction of contaminants in the 




the ability of the nitro groups in nitrocellulose to electrostatically bind to analytes, 
allowing impurities to be rinsed away without reduction in analyte concentration.[62]  
 
Table 1.1. Structure of common matrices used for MALDI. 












































































1.3.2  Inorganic Matrices  
Improved homogeneity and signal intensity have been reported when using 
inorganic salts for example copper, cobalt, silver, and gold as MALDI matrices.[65] These 
materials are dissolved with the appropriate nonvolatile solvents such as glycerol and are 
suitable for analysis of low molecular weight compounds such as methyl stearate, as well 
as, other non-polar and polar analytes since they generate low background noise. In 
addition, these matrices have been known to form small sized crystals and provide rapid 
heating, which is necessary to desorb and ionize analytes without causing decomposition 
of the analytes. These inorganic matrices generate the lowest background noise and 
highest intensity when used in MALDI-TOF.[66] The use of graphite based inorganic 
matrices works similarly and is termed Surface Assisted Laser Desorption Ionization 
(SALDI).  In addition to this SALDI technique, two other techniques that use inorganic 
matrices such as porous silicon and silicon nanowires are Desorption Ionization on 
Silicon (DIOS) and Nanowire Assisted Desorption Ionization (NALDI) respectively.[67-69]  
1.3.3  Liquid Matrices  
Although most matrices are composed of solid organic compounds, the use of 
liquid matrices has some advantages such as shot-to-shot reproducibility and the ease of 
miscibility with both hydrophobic and hydrophilic analyte.[70-72] For example, glycerol is 
a suitable liquid matrix for infrared IR-MALDI mass spectrometry; though, glycerol 
cannot be used in ultraviolet UV-MALDI mass spectrometry since it is incompatible with 
337 nm nitrogen laser.[73] However, nitro benzyl alcohol can use for UV MALDI. The 




of liquid matrices can likewise avoid non-covalent complex dissociation, which is usually 
apparent in solid matrices during the co-crystallization process.[70] Contamination at the 
source and high backing pressures under vacuum are major drawbacks that have 
prevented liquids matrices from being utilized in routine analysis.[72] 
1.4  Ionic Liquids  
Ionic liquids (ILs) are compounds composed of bulky organic ions with melting 
points equal to or less than 100°C. Typically, inorganic salts such as sodium chloride 
possess melting points higher than 800°C. Replacing the cation or anion with a bulky 
organic ion results in a lower melting point through the poor coordination between the 
bulky organic and inorganic ions.[74] ILs have been categorized into room temperature 
ionic liquids (RTILs) (melting point < 25°C) and frozen ionic liquids (FILs) (melting 
point range of 25 - 100°C).  
In general, the cations used in ILs are organic moieties of low symmetry.[75] In the 
main, cations are derived from ammonium, phosphonium, pyridinium, or imidazolium 
ions. Inorganic or organic anions such as tetrafluoroborate or nitrate have been used as 
counterions.[75] Figure 1.6 shows both common cations and anions used in the synthesis 






Figure 1.6. Common cations and anions used in ionic liquids (ILs). OTF 
(trifluoromethanesulfonatev), NTf2 (bis(trifluoromethanesulfonyl)imide), BETI 
(bis(trifluoromethylsulfonyl)imide), BF4 (tetrafluoroborate).   
 
 Ionic liquids possess many advantages over common solvents including non-
flammability, negligible vapor pressure, non-explosiveness and excellent stability at 
elevated temperatures. They are called designer solvents because of the tunability of 
various physical properties such as density, melting point, polarity and viscosity.[76] 
Further, their cations or anions can be replaced to increase or decrease their 
hydrophobicity depending on the desired application. As a result of the many features of 
ILs, they have become attractive for application in a number of techniques such as gas 




Armstrong and coworkers [54, 80, 81] introduced the concept of using room 
temperature ionic liquids (RTILs) as MALDI matrices; they produce a more 
homogeneous sample, which allows for better shot-to-shot reproducibility.[76] A 
comparison of ionic liquid matrices (ILMs) with solid matrices in MALDI revealed that 
ILMs exhibit improved reproducibility, higher sensitivity, and lower detection limits.[54] 
Although, using ILs alone does not promote analyte ion formation, the performance of 
ILs in MALDI can be improved by synthesizing them from organic matrices such as 2,5-
dihydroxy benzoic acid, or α-cyno-4-hydroxy benzoic acid.[54] 
1.4.1  Synthesis of Ionic Liquids 
The simplicity in the synthesis of ILs makes them potential candidates for the 
development of MALDI matrices in routine analysis. The synthesis of water immiscible 
ILs utilizes a metathesis or ion-exchange reaction. For example, 1-butyl-3-
methylimidazolium hexafluorophosphate is prepared by a biphasic reaction of 1-butyl-3-
methylimidazolium chloride and sodium hexafluorophosphate in the presence of water 
plus an organic solvent such as dichloromethane (DCM).[82] In this method, a biphasic 
reaction is used with an organic solvent such as dichloromethane (DCM) and water.  
Since both solvents are immiscible, the hydrophobic IL can be extracted into the organic 
phase while the salt by-product (NaCl in this case) remains in the water layer. The 







Figure 1.7. Synthesis of 1-alkyl-3-methylimidazolium hexaflurophosphate. R1: alkyl and  
R2: methyl. 
	  
Alternatively, ILs can been prepared via the acid-base reaction.[83] For example, ethyl 
ammonium nitrate was prepared by reacting ethylamine with nitric acid. Both reactants 
were dissolved in water at a temperature of 4°C. Upon reaction completion, water was 
removed by lyophilization(see Figure 1.8). 
 
	  
Figure 1.8. Reaction of ethyl ammonium nitrate. 
Another example of an acid-base reaction is the synthesis of [Py][CHCA] using 
equimolar amounts of α-cyno-4-hydroxy benzoic acid (CHCA) and pyridine (Py). Both 
compounds were dissolved in methanol and mixed. When completed, methanol was 
removed at reduced pressure (see Figure 1.9).[80] 
	  





































1.4.2  Physical and Chemical Properties of Ionic Liquids  
Based on their vast range of unique properties, ionic liquids (ILs) have been 
widely used in many fields.[84, 85] They exhibit low vapor pressure as a result of the strong 
interaction between the ions.[86] ILs have emerged as green solvents because of their 
ability to be recycled.[74] Moreover, they are conductive since they are composed of ions, 
which have high mobility in liquids or in aqueous solutions. The melting point of ILs can 
be tuned by changing the structure of the ions. As the length of alkyl chain increases, the 
magnitude of van der Waals forces also increases; thus, reducing the lattice energy and 
the melting point.[87] Another factor that affects the melting point of ionic liquids, 
compared with inorganic salts, is the size and symmetry of the bulky organic ions, which 
causes poor crystal packing.[88] 
1.5  Group of Uniform Materials Based on Organic Salts (GUMBOS) 
The development and applications of the group of uniform materials based on 
organic salts (GUMBOS) have been extensively reported.[89] These compounds are 
similar to ILs with the exception of higher melting points, from 25 to 250°C (see Figure 
1.10). Since FILs also have a range of melting points from 25 to 100°C, there is an 
overlap between GUMBOS and FILs. The physical and chemical properties of GUMBOS 
are similar to FILs and they are synthesized in a similar manner. These similar properties 
include high conductivity, high thermal stability, low vapor pressure, and non-
flammability and these properties can be tuned by varying the counter ions. For example, 
using cations that possess anticancer or fluorescent properties with an anion that 
possesses magnetic properties, multifunctional GUMBOS can be synthesized. Recently, 




for light harvesting.[85, 90] 
 
	  
Figure 1.10. Temperature difference between GUMBOS and ionic liquids. 
1.6   Tissue Imaging Using MALDI 
As previously discussed, MALDI is a powerful technique that can be utilized for 
the analysis of complex biological samples such as cells and direct tissue analysis. This 
method eliminates the need for sample preparation except sectioning of the tissue and 
addition of the matrix making the approach is less time consuming as compared to other 
imaging techniques such as staining.[91] Caprioli and coworkers [92] introduced MALDI 
imaging. This method has been used to detect intact proteins, drugs, and metabolites 
directly from tissue and have revealed reported successes in the study and identification 





1.6.1  Tissue Preparation  
Tissue samples can be isolated from any part of an animal, such as the brain or the 
liver. First, the proteins and peptides must be protected from degradation. To accomplish 
this, the sample is wrapped in aluminum foil then frozen in liquid nitrogen, which helps 
to preserve the shape and greatly slow down biological degradation.[94] In a recent study, 
a sample of brain tissue was frozen at -80°C within 30 min of surgical resection and 
stored in a sample container.[95]  
For sample analysis by MALDI imaging mass spectrometry, frozen tissue 
sections are cut by a cryostat to a thickness of 5 to 15 µm.[96] Optimization of the 
thickness of the tissue is important and this can be easily controlled and manipulated. 
Thin tissue is prone to tearing. Depending on the analyte of interest, specific size of tissue 
can be used. If the analyte is a protein and the size of the protein is between 3 to 20 kDa, 
a tissue 5 – 15 µm thick can be cut.[97] Frozen tissues are mounted on the cryostat head 
with the use of an embedding medium such as agar or a polymer (OCT). The cut sample 
is typically maintained around -25°C with the temperature dependent on the kind of 
tissue. The blade used to cut the tissue is rinsed with methanol and acetone to prevent 
contamination.[2, 98] Tissue samples are mounted on microscope slide that is coated with a 
thin (approximately 130 Å) conductive film of indium tin oxide (ITO). A schematic of 
tissue analysis is shown in Figure 1.11. After this, the tissue is kept in a dessicator for 15 
min and the matrix is applied on the tissue sample. The raster moves across the entire 
surface of the tissue that has been covered with matrix. The use of software allows the 
visualization of the spatial distribution using different colors for each m/z distributions   






Figure 1.11. Schematic diagrams showing the stages involved in the direct tissue imaging 
by MALDI IMS. 
 
1.6.2  Matrix Selection and Application 
After mounting the tissue sample on the ITO coated glass plate, the matrix is 
applied. Imaging mass spectrometry (IMS) requires a homogenous matrix for optimal 
interaction with the tissue surface. Typically, it is important that the matrix is able to 
absorb laser energy and cause the analyte to desorb from the sample surface and ionize. 
There are many suitable matrices for tissue analysis depending on the analyte. For 
example, 3,5-dimethoxy-4-hydroxy-cinnamic acid (SA) is used to detect proteins, while 































cyano-4-hydroxycinnamic acid (CHCA) is used to detect peptides or proteins.[96] 
Common solvents used to dissolve matrices are 50:50 acetonitrile or ethanol and water 
mixture.[91] Ethanol is recommended for tissues applications because it prevents the 
matrix from spreading.[91, 96] 
 Several methods are utilized to deposit the matrix on tissues for MALDI imaging 
in order to obtain better homogeneity and resolution. Typically, the matrix is deposited 
across the tissue section to avoid analyte migration. This is important for imaging tissue 
sample to study the distribution of the analyte (such as lipids, peptides and proteins) in 
tissue. A popular method for depositing the matrix is robotic spotting, which involves 
spotting along the XY direction of the matrix to apply uniform crystals on tissue. Though 
it has been shown to produce high signal-to-noise ratios and reproducible results, the 
imaging resolution is limited by the size and spacing of the matrix spots.[101] Similarly, 
spray coating, which is another method utilized for depositing the matrix on tissue, has 
the disadvantage of causing analyte delocalization if the tissue becomes too wet. Spray 
coating does however, allow for the highest spatial resolution, as densely spotted arrays 
show higher reproducibility and generally better spectra quality.[95] In the dry coating 
method, the matrix (such as CHCA or DHB) is ground to small particles. Then the matrix 
is filtered through a 20 µm pore size sieve. In the main, this method allows for good 
reproducibility and high resolution, however, it forms large crystals.[101, 102] Another 
method that has been used is spray or electrospray.[103] Noteworthy is the sublimation 
method which converts the solid matrix directly to gas without forming a liquid phase. 
This method has been reported to minimize the lateral movement of tissue lipids by 




electrospray or airbrush.[103] 
1.7  Additional Analytical Techniques 
1.7.1  Ultraviolet-Visible Spectroscopy 
Ultraviolet-visible spectroscopy (UV-vis) is a technique that is used to analyze 
molecules that absorb light in the ultraviolet and visible region of the electromagnetic 
spectrum. UV-vis measures the amount of energy absorbed by the molecules when 
exposed to light (see Figure 1.12). 
 
	  
Figure 1.12. Schematic diagram of UV-vis spectrometry. 
After light passes through a monochromator, which selects the desired 
wavelength, the sample absorbs some of the light. Using the Beer Lambert law, the 




= εCb ,   (6) 
where A  is absorbance, Io  is the intensity of the incident light, ! is the transmitted 
intensity, ε is the molar absorptivity, C is the concentration of sample and b is the 
absorption path length. The sample can be exposed to light of a range of wavelength and 




concentrations of samples can be obtained from a calibration curve generated using a 
range of concentrations of standard. 
In this work, octanol/water partition coefficients were determined by UV-vis to 
evaluate the hydrophobicity of matrices.[104] A solution of 1-octanol with water was 
shaken for 24 hours before use in order to pre-saturate the octanol with the minimal 
volume of water that is soluble within it. The 1-octanol and water were then separated; 
and, known equal volumes of pre-saturated 1-octanol and water were mixed with equal 
concentrations of each matrix and stirred for 24 hours.[104] UV-vis detection was used to 
analyze the upper (1-octanol) phase and water phase. Calibration curves for the matrices 
were made using increasing concentrations of each matrix and measuring the respective 
absorption. Using the calibration curve, the concentration of the matrix in each phase was 
determined.[85] Hence, the partition coefficient can be calculated by using the following 
equation: 
   Ko w=
[X]o,e
[X]w,e
                          (7)  
where Ko/w represents the octanol/water partition coefficient, [X]o,e  represent the 
concentration of matrix in octanol at equilibrium and [X]w,e represent the concentration 
of matrix in water at equilibrium.  
1.7.2  Fluorescence Spectroscopy 
Fluorescence spectroscopy is a sensitive analytical technique that determines the 
amount of analyte present in a sample by monitoring the amount of photons emitted when 
an atom or molecule relaxes to the electronic ground state (S0), from an excited electronic 




electronic states (Sn). After molecules reach the excited state, they return to the ground 
state causing emission. However, if excited molecules transfer to the triplet state by 
intersystem crossing, the emission from the triplet state is called phosphorescence. A 
typical Jablonski energy level diagram is shown in Figure 1.13. Since most biological 
molecules being analyzed are non-fluorescent, they are labelled with fluorescent dyes to 
aid in their detection.  
 
	  
Figure 1.13. The Jablonski diagram. 
	  
1.7.2.1 Intrinsic Protein Fluorescence  
There are three aromatic amino acids; phenylalanine (phe), tyrosine (tyr), and 
tryptophan (try) (see Figure 1.14). These compounds display intrinsic fluorescence with 




between 295-305 nm.[105] A protein’s intrinsic fluorescence is used to	   help in 
understanding the changes in the protein such as protein interaction or ligand binding.	  	  
 
	  
Figure 1.14. Intrinsic protein fluorescence A) tryptophan B) tyrosine C) phenylalanine. 
1.7.2.2 Binding Isotherm Models 
There are four characteristic regions of a binding isotherm that are displayed as 
the concentration of ionic liquids or surfactant and analyte increases (see Figure 1.15). 
The initial region, (A), is called specific binding and it occurs at low concentrations at 
high-energy sites on the analyte. The next region, (B), starts rising on a plateau of 
isotherm. In region (C), there is a massive increase in binding due to cooperative 
interactions. The last region, (D), may result from saturation suggesting that there is no 




















Figure 1.15. Schematic plot of a binding isotherm. 
 
1.7.3  Fluorescence Anisotropy  
Fluorescence anisotropy (r) is studied in a steady state by measuring and 
monitoring the binding of small molecules with peptides or proteins. This 
tool/phenomenon is also used to study conformational changes of proteins and provides 
information about the size and shape of protein. In this method, the molecule absorbs 
photons whose electric vectors are parallel to the transition moment of the fluorophores. 
After the molecules are excited in vertical polarized light, the electrical vector of 
excitation light will be oriented parallel to the vertical with the intensity of the emitted 
light, which is then measured through a polarizer.[107] The anisotropy is calculated based 
on the equation: 
r  = Ivv-GIvh
Ivv+2GIvh
 ,  (8) 
where r   is the anisotropy, Ivv , represent the vertically polarized excitation and the 
vertically polarized emission, Ivh is the vertically polarized excitation and the horizontally 





1.8  Scope of the Dissertation 
The overall objective of this work is to develop new matrices for MALDI with a 
good signal-to-noise intensity and spatial resolution in the detection of hydrophobic 
molecules. This dissertation is composed of three parts. In the first part, the organic 
matrix, aminopyrene (AP), and a series of AP-based GUMBOS, were used to vary the 
hydrophobicity of the MALDI matrix to detect various hydrophobic and hydrophilic 
peptides in comparison to a traditional matrix such as (CHCA). In the second part, studies 
the interaction between matrices and both hydrophobic and hydrophilic peptides are 
described. Scatchard plots and fluorescence anisotropy were used to analyze the binding 
between hydrophobic and hydrophilic matrices with hydrophobic and hydrophilic 
peptides. In the concluding part, a hydrophobic CHCA matrix is tuned by changing 
cation to add the counter ion oleylamine (OA) is described. [OA][CHCA] hydrophobic 
matrix, possesses a long hydrocarbon chain, and is used for the detection of hydrophobic 
proteins and lipids directly from tissue. The hydrophobic GUMBOS matrix was used for 
MALDI imaging mass spectrometry of rat tissue to study the distribution of lipids in 
tissue.  
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CHAPTER 2: GUMBOS MATRICES OF VARIABLE HYDROHOBICITY FOR 
MALDI MASS SPECTROMETRY * 
2.1  Introduction 
Matrix assisted laser desorption-ionization (MALDI) mass spectrometry (MS) is 
an important tool for rapid and sensitive analyses of biomolecules.[1] In MALDI analysis, 
the matrix is an essential component, and selection of a suitable matrix is critically 
important because the optimal performance of many matrices has been found to depend 
on the chemical characteristics of the analyte.[2-4] Therefore, there have been intense 
efforts towards development as well as evaluation of novel and effective matrices for 
MALDI-MS analyses of different analytes.[5-17] In general, MALDI matrices must 
possess specific properties that include, but are not limited to, strong absorption of laser 
radiation, ability to effectively disperse analytes, good miscibility with the solvent and 
analytes, efficient energy transfer to analyte for ionization and desorption, ability to serve 
as a good protonating and deprotonating agent, and also vacuum stability.[9]  
The majority of MALDI matrices studied so far possess hydrophilic 
characteristics, which are particularly well suited for detection of hydrophilic 
biomolecules.[17, 18] However, detection of hydrophobic biomolecules remains an elusive 
limitation for MALDI analyses. This stems from the fact that hydrophilic matrices exhibit 
low affinities for hydrophobic biomolecules. It must be emphasized that a protein 
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contains both hydrophilic and hydrophobic residues, and hence it is critical to also 
analyze hydrophobic peptides.[17, 19]  
An additional problem in the analyses of hydrophobic peptides is their limited 
solubility in commonly used solvents for MALDI-MS. To overcome this limitation, 
detergents have been employed to solubilize hydrophobic peptides in aqueous media.[17] 
These detergents, being amphiphilic, improve the solubility of hydrophobic proteins. 
However, use of surfactants at critical micelle concentrations can cause deterioration of 
the spectral quality of peptides, yielding poor signal-to-noise ratios, as well as poor mass 
resolution.[17, 20]  
Despite several attempts to develop new matrices for hydrophobic peptides and 
proteins,[16, 19, 21-26] limited success has been achieved in MALDI detection of 
hydrophobic biomolecules. For this reason, synthesis and evaluation of new matrices are 
still a priority for selective detection of hydrophobic biomolecules within complex 
biological samples. It has been observed that it is simple to detect hydrophobic 
biomolecules with hydrophobic matrices since hydrophobic matrices have good affinities 
for hydrophobic analytes.[17] Therefore, there have been several efforts to synthesize new 
hydrophobic matrices for analyses of hydrophobic biomolecules.[27-30] However, 
synthesis of such matrices often involves complex synthetic procedures, which are time 
consuming and at the same time often produce low product yields. 
Ionic liquids (ILs) have been introduced as matrices for MALDI-MS due to 
several advantages when compared to conventional matrices.[8-11, 16, 31-34] ILs are organic 
salts with melting points below 100 oC and these molecules possess several favorable 




importantly, a simple approach to “tuning” properties. Due to ease of synthesis, new 
matrices with varying hydrophobicity can be designed simply by modifying the cation or 
anion.[1] Based on results in the literature, a comparison of ionic liquid matrices (ILMs) 
with solid matrices in MALDI reveals that ILMs exhibit improved reproducibility, 
sensitivity, sample homogeneity, and detection limits.[8] However, no current studies can 
be cited which focus on tuning the hydrophobicity of ILMs through changes in the 
counter ions. 
 In our laboratory, we are investigating a variety of applications for RTILs and 
related solid phase organic salts with melting points up to 250 °C which we term a group 
of uniform materials based on organic salts (GUMBOS). In other words, organic salts 
with melting points up to 25 ºC are referred to as RTILs, while solids with melting point 
from 25 to 250 ºC are referred to as GUMBOS. GUMBOS and RTILs have been used for 
a variety of applications, primarily due to the ease with which these materials can be 
engineered for specific needs.[35-38] The hydrophobicity of such compounds can be easily 
tuned simply by changing the counter ion, which results in savings of time and energy. 
Thus, this approach is an economical method to obtain a desired product with excellent 
yield.  
Herein, we report on an investigation of 1-aminopyrene (AP) and AP-based 
GUMBOS as MALDI matrices for detection of peptides. AP was selected for these 
studies because it exhibits strong absorption at the wavelength of laser radiation (337 or 
335 nm), displays hydrophobic characteristics, and shows ability to protonate analytes. In 
this study, we synthesized a series of AP-based GUMBOS, i.e. [AP][Cl], [AP][Asc], and 




relative hydrophobicities of these compounds and CHCA were obtained by measuring 
their 1-octanol/water partition coefficients (Ko/w), which indicated that these compounds 
are much more hydrophobic than CHCA. These compounds were then examined as 
MALDI matrices for analyses of hydrophobic (valinomycin and gramicidin) as well as 
hydrophilic (bradykinin, and angiotensin II) peptides. These new MALDI matrices 
showed better performance, and at the same time controllable affinity for different 
peptides, which is indicated by changes in the signal intensity for peptides of different 
hydrophobicities. As expected, we observed that hydrophobic matrices showed better 
signal intensity for hydrophobic peptides, and that hydrophilic matrices produced 
improved signal intensity for hydrophilic peptides. To the best of our knowledge, there 
are no literature reports on the use of AP and AP-based salts as matrices for MALDI-MS.  
2.2  Experimental Section  
2.2.1  Materials  
The reagents α-cyano-4-hydroxycinnamic acid (CHCA), acetonitrile, acetone, 
methanol, ethanol, butanol, trifluoroacetic acid (TFA 99%), 
bis(trifluoromethane)sulfonimide (HNTf2, 99.95%), 1-aminopyrine (AP, 98%), 
bradykinin fragment 1-7, angiotensin II human , valinomycin , gramicidin from Bacillus 
aneurinolyticus, and ascorbic acid (99%) were purchased from Sigma-Aldrich (St Louis, 
MO, USA). Dichloromethane (99%) DCM and Hydrochloric acid (HCl) were purchased 




2.2.2  Synthesis and Characterization of GUMBOS 
Equimolar amounts of AP and hydrochloric acid were reacted to yield [AP][Cl]. 
Briefly, 1 g of AP (4.6 mmol) dissolved in 10 mL DCM was reacted with 5 mL of 0.460 
M aqueous HCl and stirred for 3 h. The solid [AP][Cl] product was washed several times 
with water to remove excess acid. The DCM was removed using rotary evaporation and 
water was removed by lyophilization. [AP][Asc], was prepared by mixing equimolar 
amounts of AP and ascorbic acid in methanol and stirring for 24 h. Likewise, [AP][NTf2] 
was prepared by reacting equimolar amounts of AP and HNTf2 in methanol and stirring 
for 24 h. In both cases, methanol was removed by use of rotary evaporation. The melting 
points of these compounds were determined using a melting point apparatus (DigitMelt 
MPA 160, Stanford Research Systems). 
2.2.3  Determination of Relative Hydrophobicity  
The 1-octanol/water partition coefficient was used to gauge the relative 
hydrophobicities of CHCA, AP, and AP-based GUMBOS. The partition coefficients 
were determined using a procedure previously developed in our group with very slight 
modifications.[35] Briefly, 1-octanol and water were shaken for 24 hours before use in 
order to correct for mutual solubility of the two solvents. A known amount of these 
compounds was then stirred in a mixture of saturated 1-octanol and water (volume ratio 
1:1) for 24 h to allow partitioning. The concentration of the compound in the 1-octanol 
phase was then determined using UV-Visible spectroscopy and the concentration in 
water by use of mass balance. Finally, the partition coefficient was calculated by use of 








where Ko/w is the octanol/water partition coefficient, [X]o,e is the concentration of solute 
in 1-octanol at equilibrium, and [X]w,e is the concentration of solute in water at 
equilibrium. 
2.2.4  Sample Preparation for MALDI  
A solution of CHCA matrix at 10 mg/mL (ca 50 mM) was freshly prepared by 
dissolving an appropriate amount of the compound in a mixture of acetonitrile and water 
(2:1,v/v) containing 0.1% TFA.[31] Solutions of AP at a concentration of 60 mM and the 
GUMBOS at a concentration of 40 mM were freshly prepared in methanol. MALDI 
samples were prepared by using a dried-droplet method.[39, 40]  
2.2.5  MALDI-TOF-Mass Spectrometry Data Acquisition 
All spectra were obtained using a MALDI-TOF mass spectrometer 
(UltrafleXtreme, Bruker, Bremen, Germany) in positive ion reflectron mode. A Nd:YAG 
laser at 355 nm wavelength with a pulse duration of 3 ns was used for ionization. The ion 
acceleration potential was 25 kV. One thousand laser shots were found to give an 
acceptable signal under nearly all conditions and were summed for each spectrum and 12 
different positions were analyzed on each spot. Data were processed using FlexAnalysis 
3.3 software (Bruker).  
2.3  Results and Discussion  
2.3.1  Preparation and Characterization of AP-based Materials 
One major requirement for a MALDI matrix is that it should possess a sufficient 
molar absorption coefficient at the wavelength of the laser used.[41] Another basic 




important factor that affects the performance of MALDI matrices is the size of the matrix 
crystals. It has been reported that smaller crystals cause improved reproducibility, and 
resolution.[42-44] Smaller crystals also volatilize completely during laser irradiation.[42] 
Therefore, we have compared the sample morphology of our different matrices and all 










Figure 2.2. Powder X-ray diffraction pattern of  [AP][NTF2]. 
	  





The sizes of the matrix crystals are shown in the images depicted in Figure 2.4. 
Microscopy was used to characterize the size of AP and AP-based GUMBOS on a 
MALDI target. Therefore, we have compared the sample morphology of our different 
compounds. The size of the matrix crystals are shown in the images depicted in (Figure 
2.4). These images were taken by using a Zeiss steREO Lumar.V12. stereomicroscope at 
a magnification of 150x. All samples were prepared on the MALDI target by using the 
dried-droplet method as described above. AP and AP-based GUMBOS formed smaller 
crystals. These crystals had sizes between 5 and 20 µm.  Thus, one of the reasons for the 




Figure 2.4. Images of different MALDI matrices in the presence of angiotensin II, The 





The hydrophobic compound, AP, was chosen as a matrix because it absorbs UV 
radiation, has the potential to donate a proton, and satisfies other requirements for a 
MALDI matrix. In addition, it can be easily converted to a GUMBOS compound such 
that its hydrophobicity can be tuned by changing the counter ion (the anion in this case).  
In this study, three different GUMBOS were prepared using 1-aminopyrene: [AP][Cl], 
[AP][Asc], and [AP][NTf2]. All three compounds are solids with melting points above 
100 ºC. These compounds were characterized by use of 1H NMR (Figures 5-8). In 
addition, 9F NMR was acquired for [AP][NTf2] and characterization-using ESI-MS was 
used to corroborate the NMR data (data not shown).  
	  







Figure 2.6. 1H NMR Spectrum a) AP top (green). b) ascorbic acid in middle (red). c) 
[AP][Asc] bottom (blue).  
 
	  







Figure 2.8. 19F NMR spectrum of [AP][NTf2]. 
The structures, molecular weights, and melting points of the compounds used in 
this study are shown in Table 2.1. 
The absorption spectra of CHCA, AP, and AP-based GUMBOS in methanol are 
shown in Figure 2.9. The absorbance band lies between 300 to 400 nm for CHCA, and 
between 300 to 420 nm for AP and AP-based GUMBOS. All of these compounds absorb 
over a similar wavelength range as compared to a CHCA matrix. The performance of our 
materials as MALDI matrices, reported in the subsequent sections, is compared with that 
of CHCA because CHCA is a commonly used MALDI matrix for low molecular weight 
biomolecule applications.[12, 37] The molar absorptivities of all compounds at 355 nm are 
also listed in Table 2.1. It is observed that AP, [AP][Cl] and [AP][Asc] have lower molar 
absorptivities as compared to CHCA, and the molar absorptivity of [AP][NTf2] is much 




Table 2.1. Structures, molecular weights, log K(o/w), molar absorptivity, and melting 
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a Melting points reported by Sigma-Aldrich and verified by us. 




























Figure 2.9. Absorbance spectra of CHCA, AP, and AP-based salts in methanol. The 
concentration of all these compounds is 50 µM. 
 
In order to estimate the relative hydrophobicity of all these compounds, 1-octanol/ 
water partition coefficients (Ko/w) were determined. The logarithm of the partition 
coefficient (log Ko/w) for each compound is listed in Table 1. Hydrophobicity is directly 
related to the value of Ko/w. As seen from the values of log Ko/w, the relative 
hydrophobicity from lowest to highest increases as α-CHCA << [AP][Asc] < [AP][Cl] < 
AP < [AP][NTf2]. This observation demonstrates that a significant change in the 
hydrophobicity of GUMBOS can be attained by a simple change of the counter ion.  
2.3.2  Evaluation of the Performance of AP and AP-based GUMBOS as MALDI 
Matrices for Hydrophobic and Hydrophilic Peptide Detection 
	  
We have evaluated the performance of this new class of materials using two 
hydrophobic (valinomycin and gramicidin) and two hydrophilic peptides (bradykinin and 
angiotensin II). Initially, the effectiveness of these AP-based matrices was evaluated by 
acquiring individual MALDI spectra for all four peptides as shown in (Figures 2.10-

























sample solution was spotted on the MALDI target and 1 µL of matrix was added and 
mixed, followed by drying under ambient conditions. Valinomycin and gramicidin, in all 
matrices including CHCA, showed a clear signal at m/z 1133.62 and 1904.06, 
respectively, which corresponds to the [M+Na]+ peak. Similarly, the [M+H]+ peak for 
bradykinin (1-7) and angiotensin II were observed at m/z 757.39 and m/z 1046.54, 
respectively, No matrix-derived peaks were observed in the spectral region of all peptides 
(Figures 2.11-2.14), indicating that these matrices do not interfere with peaks arising 

















Figure 2.12. Positive ion mode MALDI-TOF mass spectra A) only [AP][Cl]. B) 
angiotensin II with [AP][Cl]. 
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Figure 2.13. Positive ion mode MALDI-TOF mass spectra .A) only [AP][NTf2]. B) 







Figure 2.14. Positive ion mode MALDI-TOF mass spectra. A) only [AP][Asc]. B) 
angiotensin II with [AP][Asc]. 
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Figure 2.15.  Positive ion mode MALDI-TOF mass spectra CHCA with bradykinin. 
 
 
Figure 2.16. Positive ion mode MALDI-TOF mass spectra bradykinin with [AP][Asc]. 
 





Figure 2.18. Positive ion mode MALDI-TOF mass spectra bradykinin with [AP]. 
 
 
Figure 2.19. Positive ion mode MALDI-TOF mass spectra bradykinin with [AP][NTf2].  
 






Figure 2.21. Positive ion mode MALDI-TOF mass spectra [AP][Asc] with valinomycin. 
 
Figure 2.22. Positive ion mode MALDI-TOF mass spectra [AP][Cl] with valinomycin. 
 





Figure 2.24. Positive ion mode MALDI-TOF mass spectra [AP][NTf2] with valinomycin. 
 
Figure 2.25. Positive ion mode MALDI-TOF mass spectra CHCA with gramicidin. 
 





Figure 2.27. Positive ion mode MALDI-TOF mass spectra [AP][Cl] with gramicidin. 
 
Figure 2.28. Positive ion mode MALDI-TOF mass spectra [AP] with gramicidin. 
 





Table 2.2. Signal intensities and relative standard deviations for [bradykinin +H]+, 
[angiotensin II +H]+, [valinomycin + Na]+ and [gramicidin + Na]+ ions in the presence of 













CHCA 2000 102 1200 63 1200 103 1100 90 
[AP][Asc] 25000 16 9200 21 3300 29 2400 41 
[AP][Cl] 25000 23 6724 26 7300 19 2900 6 
AP 5000 41 5700 15 21000 36 7100 63 
[AP][NTf2] 2000 33 1800 16 5200 24 5500 13 
 
The relative standard deviations (RSD), which is a measure of the spot-to-spot 
reproducibility, were evaluated by using the signal intensity measured at 12 different 
positions (Table 2.2). The laser settings used were the same for all matrices. In all 
measurements, only the spectra having a resolution greater than 10,000 were collected. 
Examination of Table 2.2 reveals that improved spot-to-spot reproducibility and 
significant enhancement (10-15 times) in signal intensity are obtained when using AP-
based matrices as compared to the conventional CHCA matrix. The low signal intensity 
in the case of [AP][NTf2] is attributed to the relatively low molar absorption coefficient 
of this salt as compared to AP and other AP-based GUMBOS. In addition, low signal 
intensity in [AP][NTf2] could also be ascribed to formation of a hydrogen bonding 
network between the highly electronegative atoms in the [NTf2]- anion and the AP cation. 
The hydrogen bonding between cation and anion in [AP][NTf2] may also inhibit proton 
transfer from matrix to the analytes, thereby accounting for poor performance.[45, 46]  
The results obtained using AP and AP-based GUMBOS matrices for hydrophilic 
(bradykinin, angiotensin II) and hydrophobic peptides, (valinomycin and gramicidin) are 




the hydrophobic peptides as compared to the hydrophilic peptides in the hydrophobic 
matrices (right hand side of Figure 2.30) and relatively high signal intensity for the 
hydrophilic peptides in the more hydrophilic matrices (left hand side of Figure 2.30). The 
propensity for hydrophobic/hydrophilic matrix favoring hydrophobic/hydrophilic analyte 
is not a strict rule. For example, angiotensin II and valinomycin have nearly the same 
intensity with [AP][Cl] and angiotensin and gramicidin have nearly the same intensity 
with [AP]. Nonetheless, the general trend of “like favors like” holds, when the results are 
taken in its entirety. Likewise, there is some variation in absolute signal intensity from 
matrix to matrix; for example, [AP][NTf2] has a relatively low signal for all matrix 
compounds, most likely due to its low absorptivity. However, the hydrophobic 
[AP][NTf2] matrix clearly favors the hydrophobic peptides in comparison to the 
hydrophilic peptides. 
For all peptides, reproducibility is improved with GUMBOS matrices as 
compared to a conventional CHCA matrix. The improved reproducibility of the signal 
with these matrix materials likely results from a more homogeneous distribution of 






Figure 2.30. Average MALDI signal intensity as a function of the logarithm of the 
partition coefficient Log K(o/w) for (left to right) [AP][Asc], [AP][Cl], [AP], and 
[AP][NTF2]; a larger partition coefficient indicates a more hydrophobic matrix.  
 
We also analyzed the data by obtaining the ratios of signal intensity of each 
hydrophilic peptide to each hydrophobic peptide (bradykinin/gramicidin, 
bradykinin/valinomycin, angiotensin II/valinomycin, and angiotensin II/gramicidin) in 
order to normalize the effect. A plot of the ratio of signal intensity against the logarithm 
of partition coefficient of AP and AP-based GUMBOS shows a clear trend with 
hydrophobicity (Figure 2.31). More specifically, the ratio of the signal intensity is found 




























Figure 2.31. Intensity ratio for hydrophilic peptide/hydrophobic peptide as a function of 
log partition coefficient AP and AP-based GUMBOS. 
2.3.3  Analysis of Hydrophobic and Hydrophilic Peptide Mixtures 
Peptide mixtures were also analyzed using each matrix separately. An equimolar 
amount of hydrophobic (valinomycin) and hydrophilic (angiotensin II) peptide was 
mixed and the mixture was spotted on a MALDI target using a dried-droplet method. 
Each spot was analyzed at 12 different positions and the average intensity and the relative 
standard deviation were calculated. The resulting signal intensities of the mixtures 
obtained with different AP-based matrices were compared with a conventional CHCA 
matrix. In spite of the same concentration used for both peptides with the [AP][Asc] 
matrix, higher signal intensity was observed for angiotensin II than for valinomycin 
(Figure 2.32). This suggests that [AP][Asc], a hydrophilic matrix, exhibits a higher 
affinity for the hydrophilic peptide as compared to the hydrophobic peptide. Similarly, 
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II and lower intensity for valinomycin (Figure 2.34 and 2.35). Thus, the hydrophilic 
matrices result in better signals for the hydrophilic peptides.  
To investigate the hydrophobic peptides, a hydrophobic matrix was employed. 
Aminopyrene, a hydrophobic matrix, showed opposite results for a mixture of 
hydrophilic and hydrophobic peptides. In this case, higher signal intensity was observed 
for valinomycin as compared to the angiotensin II for the same molar concentration of 
peptides as shown in (Figure 2.33). Thus, it is likely that the enhanced signal for the 
hydrophobic peptide is due to its higher affinity for the hydrophobic matrix. 
 
	  
Figure 2.32. Positive ion mode. MALDI MS Spectrum of equimolar mixture of 





Figure 2.33. MALDI MS spectra for equimolar mixture of angiotensin II and 




Figure 2.34. CHCA hydrophilic matrix detected higher intensity hydrophilic peptide 






Figure 2.35. [AP][Cl] hydrophilic matrix detected higher intensity hydrophilic peptide 
(angiotensin II) compared with hydrophilic peptide (valinomycin). 
The average signal intensity obtained for the mixture was plotted against the 
logarithm of the partition coefficient (log Ko/w) of different AP-based matrices (Figure 
2.36). The relative standard deviation is highest in CHCA as compared to the AP and AP-
GUMBOS matrices. In terms of reproducibility and signal intensity for both hydrophobic 
and hydrophilic peptides, AP-based matrices are better performing as compared with 
CHCA. In terms of relative intensity, the hydrophilic angiotensin II has approximately 
three times the signal intensity as the hydrophobic valinomycin for all but the most 
hydrophobic matrix [AP][NTf2]. This supports the general trend of hydrophobic analytes 
requiring a hydrophobic matrix, but also suggests a nonlinear effect in which there is a 
threshold for matrix hydrophobicity above which ionization of the more hydrophobic 




within a narrow range will be critical for selective ionization of the hydrophobic 
components in a sample.  
 
	  
Figure 2.36. Signal intensities for a mixture of a hydrophilic (angiotension II ) and 
hydrophobic (valinomycin) peptide at equimolar concentration in matrices of different  
hydrophobcities. (CHCA:-1.72), ([AP][Asc]:0.81), ([AP][Cl]:1.02) and (AP:1.42). 
 
Table 2.3. Intensity for mixture of hydrophilic (angiotension II ) and hydrophobic 
(valinomycin) peptides at equimolar concentration in different matrices of variable 
hydrophobcities. 






CHCA 3300 92 1000 100 
[AP][Asc]  2700 72 600 63 
[AP][Cl] 8300 32 2500 25 
AP 1400 48 8400 30 
 
The result for the ratio of angiotensin II/ valinomycin as a function of the 
hydrophobicity of the matrices is shown in (Figure 2.37). A plot of the ratio signal 
intensity against the logarithm of partition coefficient of matrices shows a clear trend: as 

























peptides decreases. This experiment was designed to normalize the effect of both 
hydrophobic and hydrophilic peptides at similar spots. 
 
	  
Figure 2.37. Ratio of average intensity (angiotensin II/ valinomycin) versus log (Ko/w) of 
matrices. 
 
2.4  Conclusions 
In this work, AP and AP-based GUMBOS of variable hydrophobicities were used 
as MALDI matrices. A series of AP-based GUMBOS were synthesized and 
characterized. A simple, facile and inexpensive approach was used to tune the 
hydrophobicity of AP based matrices. The performance of these salts, along with AP as 
MALDI matrices for detection of hydrophobic and hydrophilic peptides was evaluated. 
Tuning the hydrophobicity of the matrix by altering the counter ions in AP-based 
GUMBOS changes its performance with peptides. Hydrophilic and hydrophobic peptides 
were determined using AP and AP-based GUMBOS and compared with conventional 
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matrices for different peptides depended on the matrix hydrophobicity. We have observed 
that increasing the hydrophobicity of a matrix increases the affinity to hydrophobic 
peptides after laser desorption. An increase in hydrophilicity of the matrix in the order of 
CHCA > [AP][Asc]> [AP][Cl]> AP led to a higher affinity for hydrophilic peptides. 
Likewise, the signal intensity for hydrophobic peptides increased when the 
hydrophobicity of the matrix was increased. A mixture of hydrophilic and hydrophobic 
peptides, demonstrated that these new matrices of variable hyrophobicities result in a 
similar trend in signal intensity, e.g. AP, a hydrophobic matrix, increased sensitivity of 
hydrophobic peptides, whereas the signal intensity for hydrophilic peptides were lower. 
Similarly, [AP][Cl] and [AP][Asc] and CHCA showed increased sensitivity for 
hydrophilic peptides and suppressed the detection of hydrophobic peptides. It was 
observed that CHCA, [AP][Asc], and [AP][Cl], showed good affinity for hydrophilic 
peptides. In ongoing work, these GUMBOS-based matrices and others are being used to 
enhance and selectively detect peptides in tissue samples for MALDI imaging. 
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CHAPTER 3: SELECTIVE BINDING AFFINITIES OF AP AND AP-BASED 
GUMBOS FOR HYDROPHOBIC AND HYDROPHILIC PEPTIDES IN MALDI 
MS 
3.1  Introduction  
With advantages such as rapid analysis, mass accuracy, good resolution, and high 
sensitivity, matrix assisted laser desorption ionization (MALDI) mass spectrometry has 
been widely used to determine the molecular weight of both hydrophobic and hydrophilic 
biomolecules.[1-4] Moreover, MALDI, unlike other techniques, can be used to detect 
mixtures of analytes on samples, such as tissues.[5, 6] 
Matrix is one of the key components of the MALDI analysis. Here, we have 
introduced new matrices with variable hydrophobicity. A clear understanding of the 
interaction between MALDI matrix and analytes is imperative to obtain good 
performance. Biomolecules possess both hydrophobic and/or hydrophilic properties 
depending on the amino acids they are composed of. Those biomolecules that mostly 
have hydrophobic amino acids are hydrophobic; however, some biomolecules exhibit 
both properties, which enable amphiphilic molecules to interact with them. [7-10] Various 
methods, such as confocal laser scanning microscopy,[11] MALDI imaging,[12] scanning 
electron microscopy,[13, 14] and X-ray crystallography[15] have been used to study the 
incorporation of analytes within the matrix. Dai et al[16] demonstrated that confocal 
microscopy could be used to provide information on the distribution and incorporating 
analyte within a matrix by using either different sample preparation techniques or 
morphologies of MALDI crystals. Additionally, MALDI imaging was used to study the 




Hydrophobic biomolecules are difficult to detect using MALDI-MS because of 
their poor solubility in polar solvents.[2] As a result, surfactants have been used to 
improve the solubility of hydrophobic biomolecules in aqueous media.[2] However, 
binding of the biomolecules to the surfactant may occur depending on the properties of 
the surfactant used.[4, 8] Although surfactants can be beneficial, they have limitations and 
can adversely affect both mass accuracy and signal to noise ratio.[17]  
The function of the group and structure present in biomolecules can be understood 
by their interaction with surfactants, which have been studied using various model 
proteins and properties of surfactant.[18-21] The hydrophobic bulky moieties of surfactants 
have been used to attract hydrophobic moieties of analytes.[22] Anionic surfactants, for 
example, sodium dodecyl sulfate (SDS) bind strongly with the protein bovine serum 
albumin (BSA), causing denaturation.[23, 24] However, anionic and cationic surfactants 
show a lower tendency to interact with proteins because the electrostatic interaction based 
on the pH is used. Both cationic and anionic surfactants show similar binding isotherm 
shapes when used with the same protein. [7]  
The Warner research group has recently introduced a new class of materials 
defined as a group of uniform materials based on organic salts (GUMBOS) that have 
melting points between 25 °C to 250°C.[25-27] They have similar physical and chemical 
properties as frozen ionic liquids, but have melting points from 25 to 100°C. GUMBOS 
are frequently composed of bulky organic anions and cations: however, similar to ionic 
liquids, the properties of GUMBOS can be tuned by changing one of the ions.[28]   
In order to overcome the challenges faced with matrix–analyte combinations in 




using various counter anions in order to tune their hydrophobicities for use as MALDI 
matrices. The interaction of the MALDI matrices with gramicidin, a hydrophobic peptide, 
and angiotensin II, a hydrophilic peptide, was studied using absorbance and fluorescence 
spectroscopy. Scatchard analysis and fluorescence anisotropy studies were then 
performed to compare the behavior of hydrophobic and hydrophilic peptides with the 
matrices. The results showed that the interaction between the matrices and the analytes 
varied with the hydrophobicity of both components. Decreasing the hydrophobicity of the 
matrix resulted in an increased interaction with hydrophilic analytes. Binding studies 
between matrices and peptides were used to better understand the mechanism of 
interaction between peptides and matrices. In this study, α-cyano-4-hydroxycinnamic 
acid (CHCA) was used as a control.  
3.2  Experimental  
3.2.1  Materials  
The reagents (CHCA), acetonitrile, acetone, methanol, ethanol, trifluoroacetic 
acid (TFA, 99%), bis(trifluoromethane) sulfonimide (HNTf2, 99.95%), ascorbic acid 
(Asc,99%), and 1-aminopyrene (AP, 98%) were purchased from Sigma-Aldrich. 
Gramicidin, valinomycin, and angiotensin II, were purchased from Sigma-Aldrich. All 
chemicals were received and used without further purification. 
3.2.2    Instrumentation  
3.2.2.1 MALDI-TOF-MS Analysis  
All mass spectrometry experiments were performed using an UltrafleXtreme 




nm) and pulse duration of 3 ns was used for ionization. All the experiments were 
obtained using positive ion reflectron mode with the ion acceleration potential of 25 kV. 
Finally, laser shots amounted to one thousand shots for each spectrum; data were 
processed using Flex Analysis 3.3 software (Bruker); and the matrix solution consisted 
of 10 mg/mL CHCA in 2:1 acetonitrile and 0.1% TFA which was prepared in water. 
3.2.2.2 Fluorescence Spectra 
Fluorescence emission spectra were obtained using a Spex Fluorolog-3 (Jobin 
Yvon, Edison, NJ) at room temperature equipped with a 450-W xenon lamp and R928P 
photomultiplier tube (PMT) emission detector. A 0.4 cm quartz cuvette was used. An 
excitation at a wavelength of 280 nm was used due to the presence of tryptophan. 
Emission spectra were collected between 290 – 400 nm.  
3.2.2.3 Determination of Binding Parameters of CHCA, AP, and AP-based 
GUMBOS to Peptides 
	  
A titration procedure was used to estimate the strength of binding of CHCA, AP, 
and AP-based GUMBOS with the two peptides employed in this study. The 
concentration of the peptides was 10 µM and the concentration of the matrices ranged 
from 0 to 100 µM. The data of the Scatchard analysis was employed to determine the 
binding isotherms, stoichiometries, and dissociation constants.[29-31] In biological 
systems, there is a receptor for the binding of ligands, L. The number of ligands binding 
per site, the binding constants, and the regions of binding were determined using 
Scatchard plots. The various parameters used to interpret the resulting Scatchard plot are 
described below; 




α =(I-Io)/(Im-Io) ,      (1)  
and the concentration of the bound matrix is  
Mb=α [total concentration] ,     (2)  
where Iois the fluorescence intensity of the peptide without matrix, I is fluorescence 
intensity when the peptide and matrix are in equilibrium, and Im represents fluorescence 
intensity when the peptide is completely saturated with the matrix. Free matrix 
concentration was determined by 1-[bound matrix]. The parameter, !, is defined as 
α total matrix /[total peptide] , and free matrix concentration !  was obtained from 
[total matrix](1-α). Equilibrium binding constant, k , was determined by the linear 
portion of scatchard plot ( ν
C
 vs ν). Binding sites (n) were quantified using different 
regions of concentrations.  
3.2.2.4 Determination of Fluorescence Anisotropy of CHCA, AP, and AP-based  
GUMBOS to Peptides   
	  
Fluorescence anisotropy, r, measures the average angular displacement of the fluorophore 
and can be calculated using the following equation:  
r= Ivv-GIvh
Ivv+2GIvh
 ,       (3) 
where Ivv and Ivh are the fluorescence emission intensity measured parallel or 
perpendicular to the vertically polarized excitation, respectively. G represents the grating 
factor, which is included to correct for the wavelength dependent response of the 




3.3  Results and Discussion 
3.3.1 MALDI Analysis  
MALDI-MS detection of hydrophobic biomolecules remains difficult due to the 
inherent hydrophilicity of most MALDI matrices. In this study, 1-aminopyrene (AP) and 
AP-based GUMBOS were investigated as MALDI matrices for hydrophobic peptides, 
then their performance was evaluated in terms of selectivity towards two peptides, 
gramicidin, a hydrophobic peptide, and the angiotensin II, a hydrophilic peptide. AP was 
selected specifically for these studies because it exhibits strong absorption at the 
appropriate laser wavelength; as well, it displays hydrophobic characteristics and the 
ability to protonate the analytes. In this study, we synthesized and tested a series of AP-
based GUMBOS including [AP][ascorbate] ([AP][Asc]), and [AP][bis(trifluoromethane) 
sulfonamide] ([AP][NTf2]).[27] The relative hydrophobicity of these compounds and 
conventional MALDI matrix, CHCA, was estimated by measuring their 1-octanol/water 
partition coefficients (Ko/w). The relative hydrophobicity occurs in the following order 
CHCA=(-1.72) << [AP][Asc]=(0.81)< AP < [AP][NTf2]=(1.54). The compounds were 
then evaluated as MALDI matrices for analysis of hydrophobic (gramicidin) as well as 
hydrophilic (angiotensin II)	   peptides. An equimolar amount of hydrophobic and 
hydrophilic peptide were mixed and analyzed using AP and AP-based GUMBOS in 
comparison with CHCA, a conventional matrix for peptides. Angiotensin II and 
gramicidin showed peaks at m/z 1046.54 and 1904.06, respectively, which corresponds to 
the sodiated adduct [M+Na]+. Figure 3.1 and 3.2 show the MALDI mass spectra of 
angiotensin II and gramicidin mixture as analyzed using AP and [AP][Asc] as matrices. 




peptides using AP and [AP][Asc] as matrices reveal a clear difference in signal with 
variation in signal intensity due to the hydrophobicity of matrices. In (Figure 3.2), the 
matrix [AP][Asc], which is less hydrophobic than AP, detected angiotensin II, a 
hydrophilic peptide, with higher intensity than gramicidin. Conversely, when AP was 
used as a matrix, gramicidin was detected with higher signal intensity than angiotensin II 
(Figure 3.1). When CHCA, the most hydrophilic matrix, was used, angiotensin II was 
detected with higher intensity than gramicidin,(Figure 3.3). When [AP][NTf2], the most 
hydrophobic matrix, was used gramicidin detected with higher intensity than angiotensin 
II  (Figure 3.4). These results reveal that AP improved the signal of hydrophobic 
peptides. The selective detection of hydrophobic or hydrophilic peptides by variation of 
hydrophobicities of the matrix materials implies some specific interactions between the 
matrix and analyte, such as cooperative binding, which will be investigated in the later 





Figure 3.1. MALDI mass spectra of a mixture of gramicidin (hydrophobic) and 
angiotensin II (hydrophilic) with (AP Log K(o/w)=1.42). 
 
	  
Figure 3.2. MALDI mass spectra of a mixture of gramicidin (hydrophobic) and 






Figure 3.3. MALDI mass spectra of a mixture of gramicidin (hydrophobic) and 
angiotensin II (hydrophilic) with A) CHCA Log K(o/w) =(-1.72). 
	  
	  
Figure 3.4. MALDI mass spectra of a mixture of gramicidin (hydrophobic) and angiotensin II 






3.3.2  Spectral Studies of AP and AP-based GUMBOS 
3.3.2.1 Absorbance and Fluorescence 
The use of AP and AP-based GUMBOS as matrices in MALDI to detect 
biomolecules requires investigation of their affinity with the analyte, which can be 
studied using spectral behavior. Methanol solutions of AP and AP-based GUMBOS had 
similar absorbance spectra with a λmax near 360 nm (Figure 3.5). Generally, the 
absorbance spectra of AP and each AP-based GUMBOS at 20 μM revealed that anion 
variations have an effect on the shape of the spectra. However, the absorbance varied 
slightly with anion. In the case of [AP][NTf2], the spectrum had an absorption shoulder in 
the blue region relative to the main peak.  
	  
Figure 3.5. Absorbance spectra of 20 µM AP and AP-based GUMBOS. The solvent is 
methanol. 
An intense emission signal from AP and AP-based GUMBOS appears at 426 nm 
























the expected mirror-image rule (Figure 3.6). The Stokes shifts were similar regardless of 
the anion and ranged from 66 to 69 nm (Table 3.1). Thus, the anion didn’t affect the 
fluorescence excitation and emission properties of these compounds significantly.  
 
Table 3.1. Stokes shift for AP and AP-based GUMBOS. 






AP 357 426 69 
[AP][Asc] 360 426 66 
[AP][NTf2 ] 360 426 66 
	  
 
Figure 3.6. Normalized absorbance (Blue) and fluorescence emission (red) spectra of (A) 
AP, (B) [AP][Asc]and (C) [AP][NTf2].	  
	  
 
Figure 1: Normalized absorbance (Blue) and emission (red) spectra of (A) AP, (B) 


































































3.3.2.2 Binding Studies and Scatchard Analysis 
	  
The mechanism of ligand, in this case the GUMBOS matrix, binding to peptides 
was studied through excitation of tryptophan (trp), tyrosine (tyr), and phenylalanine (phe) 
amino acids by fluorescence.[31, 32] In this study, angiotensin II and gramicidin were 
chosen to study the binding between matrix and peptide. Both peptides have tryptophan 
(trp) residues, which absorb at 280 nm. In the absence of matrix, the fluorescence of 
angiotensin II and gramicidin had an emission band between 290 to 400 nm (Figure 3.7). 




Figure 3.7. The fluorescence spectra of gramicidin and angiotensin II without	  the	  use	  in	  
the	  absence	  of	  a	  matrix. 
 The fluorescence of both peptides was gradually quenched and red-shifted as the 





























Figure 3.8. AP with 10 µM angiotensin II. 
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APAsc 90 uM 10uM Ang II  
APAsc 80 uM 10uM Ang II 
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APAsc 60 uM  10uM Ang II 
APAsc 50 uM  10uM Ang II 
APAsc 40 uM 10uM Ang II 
APAsc 30 uM  10uM Ang II 
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APAsc 10 uM  10uM Ang II 
APAsc 1uM 10uM Ang II 
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Figure 3.10.  [AP][NTf2] with 10 µM angiotensin II. 
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Figure 3.12. AP 10 µM Gramicidin.	  
































AP 100 uM 10uM G 
AP 90 uM 10uM G 
AP 70 uM 10uM G 
AP 60 uM 10uM G 
AP 50 uM  10uM G 
AP 40 uM  10uM G 
AP 30 uM  10uM G 
AP 20 uM 10uM G 
AP 10 uM 10uM G 
AP 1uM 10uM G 

























100 uM APAsc 10uM G  
90 uM APAsc 10uM G  
70 uM APAsc 10uM G  
80 uM APAsc 10uM G  
70 uM APAsc 10uM G  
60 uM APAsc 10uM G  
50 uM APAsc 10uM G  
40 uM APAsc 10uM G  
30 uM APAsc 10uM G  
10 uM APAsc 10uM G  
1uM APAsc 10uM G  
































AP 100 uM 10uM G 
AP 90 uM 10uM G 
AP 70 uM 10uM G 
AP 60 uM 10uM G 
AP 50 uM  10uM G 
AP 40 uM  10uM G 
AP 30 uM  10uM G 
AP 20 uM 10uM G 
AP 10 uM 10uM G 
AP 1uM 10uM G 

























100 uM APAsc 10uM G  
90 uM APAsc 10uM G  
70 uM APAsc 10uM G  
80 uM APAsc 10uM G  
70 uM APAsc 10uM G  
60 uM APAsc 10uM G  
50 uM APAsc 10uM G  
40 uM APAsc 10uM G  
30 uM APAsc 10uM G  
10 uM APAsc 10uM G  
1uM APAsc 10uM G  




Figure 3.14. [AP][NTf2] 10 µM Gramicidin.	  
Figure 3.15. CHCA 10 µM Gramicidin.	  
	  
Scatchard analysis was used in order to study the binding between matrices and 
peptides, which displayed four characteristic regions with increasing concentrations: 
specific binding, non-specific binding, negative cooperative binding, and positive 
binding.[33] There are four characteristic regions in the binding isotherm of an analyte 
with matrices as the concentration of matrices increases. Specific binding occurs when 
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monomers to the specific high-energy sites of the analytes. Non-cooperative binding 
occurs when the isotherm slowly increases and a plateau region may occur. Within this 
boundary the binding of matrices to biomolecules is unaffected. Another region is called 
the cooperative binding region where a massive increase in binding occurs due to 
allosteric binding effects. The last region occurs when the matrices become saturated, 
resulting in a plateau in the binding isotherm. This means the excess matrix is not 
binding to analyte.[9, 20, 31, 33]   
The observed binding of angiotensin II with AP in the concentration range of 1 to 
50 µM demonstrated several types of interactions. The first region was specific binding 
indicating strong interaction between the matrix and analyte whereas the second region 
was negative cooperative binding. The plot for AP with gramicidin also demonstrated 
two linear regions in the first region, from 1 to 30 µM, being the specific binding region 
and the second region, from 40 to 100 µM, being negative-cooperative binding 
suggesting similar type of interaction with both peptides. However, the binding constant 
for the binding of AP to the hydrophobic peptide gramicidin was 10 times higher than 
for the binding to the hydrophilic peptide angiotensin II (Table 3.2) and see appendix 
(Figure A1 to Figure A8). Table 3.2 shows the observations of the peptides binding with 
various matrices. Based on the binding constants, the hydrophobic matrix [AP][NTf2] 
also exhibited strong binding with the hydrophobic peptide compared to the hydrophilic 
peptide. [AP][Asc] demonstrated a non-cooperative followed by negative cooperative 
binding with angiotensin II, whereas it demonstrated a specific, positive cooperative, 
and finally negative cooperative binding with gramicidin. The binding constant for this 




the hydrophobic peptide, suggesting its capability of distinguishing the peptides in terms 
of hydrophobicities. The conventional MALDI matrix CHCA was found to exhibit a 
positive followed by a negative cooperative binding region with angiotensin II whereas 
with gramicidin the binding was mostly non-cooperative. However, the binding constant 
for binding with hydrophilic angiotensin and hydrophobic gramicidin was comparable. 
At low concentrations, AP displayed non-specific binding while AP based GUMBOS 
displayed specific binding with angiotensin II. Thus, similar to AP, [AP][NTf2] had 
higher binding with gramicidin than angiotensin II. [AP][Asc] behaved differently from 
the hydrophobic matrices AP and [AP][NTf2].  
3.3.2.3 Fluorescence Anisotropy of CHCA, AP and AP-based GUMBOS 
 
Results from fluorescence anisotropy studies of CHCA, AP, and AP-based 
GUMBOS are presented in (Figure 3.16-3.17). The anisotropy studies suggest the 
hydrophobic peptide (gramicidin) tends to bind more strongly to hydrophobic matrices 
(AP, and [AP][NTf2]) and the greater the hydrophobicity of the matrices, the greater the 
strength of binding, as indicated by greater differences in anisotropies between bound and 
unbound states. In contrast, the same hydrophobic matrices show no specific tendency of 
binding to the hydrophilic peptide (angiotensin II), which is clearly indicated by the 
overlapping anisotropy values for both bound and unbound states. Similarly, the 
hydrophilic GUMBOS [AP][Asc] and conventionally used MALDI matrix, CHCA, 
which is very hydrophilic as observed from Ko/w, exhibited greater tendency of binding to 
the hydrophilic peptide angiotensin II and no specific binding to the hydrophobic peptide 
gramicidin. Thus, the result shows from these studies peptides can be differentiated based 




tuning of the GUMBOS counter anion. These results also help explain the performance of 
these GUMBOS as matrices in MALDI in order to distinguish between hydrophilic and 
hydrophobic peptides, 
Table 3.2. Scatchard analysis data for the interaction of the hydrophobic peptide 
(gramicidin) and hydrophilic peptide (angiotensin II) with MALDI matrices (CHCA, AP 
and AP-based GUMBOS) 	  










1-30 µM Non-Specific Binding 
19.05 
40-100 µM Specific Binding 
Angiotensin	  II [AP][Asc] 
1-30µM Specific Binding 
7.52 40 – 60 µM + Cooperative Binding 
70 – 100 µM -Cooperative Binding 
Gramicidin [AP][Asc] 
1-40µM Specific Binding 
 
0.12 50-100 µM Specific binding 
Angiotensin	  II [AP][NTf2] 
1-60 µM + Cooperative Binding 
8.33 
70- 100 µM -Cooperative 
Gramicidin [AP][NTf2] 
1-30µM Specific 12.27 40-90 µM - Cooperative Binding 
Angiotensin	  II CHCA 1-40 Non specific 12.72 50-100 µM - Cooperative Binding 







Figure 3.16.	  Fluorescence anistropy studies using a hydrophobic (gramicidin) and 
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Figure 3.17. Fluorescence anistropy studies using a hydrophobic (gramicidin) and 
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In this work we have demonstrated that AP and AP-based GUMBOS matrices 
selectively interact with both hydrophilic and hydrophobic peptides, even when mixed, 
based on their hydrophobicities. The hydrophilic matrices were selective to hydrophilic 
peptides while hydrophobic matrices were selective to hydrophobic peptides. AP and 
[AP][NTf2] were more selective to hydrophobic analytes when hydrophilic and 
hydrophobic analytes were mixed at the same concentration. CHCA	   and	   [AP][Asc]	  
showed	  good	  affinity	   for	  hydrophilic	  peptides.	  The binding studies demonstrated the 
binding between the matrix (hydrophobic or hydrophilic) and analyte was different in 
each case. The binding type and the binding constant were both found to be specific to 
the matrix/analyte combination. In	  ongoing	  work,	   these	  GUMBOS	  based	  matrices	  are	  
being	   used	   to	   enhance	   and	   selectively	   detect	   hydrophobic	   compounds	   in	   tissue	  
samples	  for	  MALDI	  imaging.	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CHAPTER 4: OLEYLAMINE α-CYANO-4-HYDROXYCINNAMIC ACID 
[OA][CHCA] AS A MATRIX FOR MALDI IMAGING MASS SPECTROMETRY 
OF LIPIDS 
4.1 Introduction  
Lipids can be classified into phospholipids, glycerolphospholipids, cholesterols, 
and fatty acids. These molecules are the fundamental building blocks of biological 
membranes.[1, 2] There are many types of lipids, each with different chemicals and/or 
physical properties depending on the variety of functional groups present. Lipids are 
divided into simple and complex classes based on structure and function. Simple lipids 
include cholesterols and fatty acids, while complex lipids include glycerolphospholipids. 
In general, lipids have one or more long chain hydrophobic tails connected with various 
groups of different polarity and hydrophobicity. Phospholipids, lipids with a phosphate 
group, are important structural components of cell membranes and they are a major 
component of the cell. Localization studies of lipids in brain tissue are important, because 
a change in the phospholipid distribution in the brain tissue can indicate the presence of 
diseases such as Alzheimer’s.[3-5]  
Phospholipids in tissues can be analyzed by mass spectrometry after extraction 
and purification; however, these methods are tedious and labor-intensive. Various 
imaging methods such as fluorescence spectroscopy,[6] infrared spectroscopy,[7, 8] as well 
as mass spectrometry are used to measure lipids directly on tissues.[9] Matrix assisted 
laser desorption ionization imaging mass spectrometry (MALDI IMS)[10, 11], has become 
a powerful technique for direct analysis of biological compounds such as lipids, peptides, 
and proteins. MALDI IMS is used for detecting, identifying, and characterizing analytes 




salts and other contaminants.[12, 13] MALDI IMS is a particularly useful technique for 
biomolecules analysis in tissues since it can be performed directly on tissues, eliminating 
the need of extraction or purification steps.[14] Additionally, the use of mass spectrometry 
allows the detection of all biomolecules in the sample as opposed to other techniques like 
fluorescence microscopy where intrinsic fluorescence or fluorescent labeling is 
required.[6, 15] MALDI IMS has also been developed for biological, medical, 
pharmaceutical, and biomarker applications because it can be used over a wide mass 
range that includes many biomolecules.[16-18]   
Recently, the development of MALDI has enabled the exploration of complex 
lipids and drugs in biological tissues for use in cancer or neuroscience studies.[19] This 
method helps detect drugs and biomarkers on tissues.[20] MALDI IMS has been used for 
detecting and studying lipids such as phospholipids and sphingolipids, which are the most 
abundant ions observed by the MALDI IMS in the brain [14] or liver[21]. 
The requirements of matrices used in MALDI IMS include providing protons to 
analytes, absorbing at the wavelength of the laser, and mixing well with analytes in 
tissues. When synthesizing a new matrix, it is important that the matrix gives good 
spectral quality (in regard to sensitivity, resolution, and intensity) and stability in 
vacuum. Crystallization of the matrix on tissue is another important factor to achieve 
homogeneity. When a uniform layer of the matrix crystallizes on the tissues, the 
homogeneity and signal are improved [20, 22] Various matrices have been used for MALDI 
IMS. For example, 2,5-dihydroxybenzoic acid (DHB) and 2,4,6-trihydroxyacetophenone 
(THAP) are commonly used for detecting lipids in both negative and positive mode. 




sample-to-sample reproducibility and molecular delocalization.[23-27] Other matrices that 
have been used for detecting lipids are 2-mercaptobenzothiazole (MBT) and 9-
aminoacrine (9-AA). MBT yields high reproducibility from spot to spot due to the 
formation of small crystals, which increases the homogeneity of the matrix deposit.[21, 28] 
A drawback of using MBT as a matrix is that it forms a large amount of fragments below 
500 Da, which can interfere with the analysis of analytes in that region.[21, 29] 9-AA is 
used to detect low molecular weight metabolites and it has been used for detecting lipids 
in negative ion mode. Some matrices perform well in only a particular polarity mode.[9, 26, 
30, 31]  
Ionic liquids (ILs) have been used as matrices for imaging and detecting 
biomolecules.[32] ILs are composed of bulky organic ions and have melting points less 
than or equal to 100 °C. IL matrices are divided into two categories: those that have 
melting points less than 25 °C and frozen ionic liquids (FILs), which have melting points 
between 25 to 100 °C. ILs have several advantages over conventional matrices such as 
stability under the high vacuum. Furthermore, they give high signal intensity, good signal 
to noise ratio, and a large number of compounds can be detected on tissues. A Group of 
Uniform Materials Based on Organic Salts (GUMBOS) have melting points between 25 
and 250 °C and their properties are similar to those of ILs, with the exception of their 
physical state. Like ionic liquids, the counter ions used to make GUMBOS can be 
changed to tune the materials for specific applications.[33] 
In the present study, we have synthesized and applied a new long-chain alkyl 
GUMBOS, [OA][CHCA], as a MALDI matrix for the detection of lipids. The use of this 




homogeneity is in part due to the hydrophobic tail, which aids in dissolving hydrophobic 
proteins. The performance of [OA][CHCA] was found to be equal to or better than 2,5-
dihydroxylbenzoic acid (DHB). Specifically, a significant improvement in signal and 
sensitivity were observed when [OA][CHCA] was used for detecting hydrophobic 
proteins. When [OA][CHCA] was used as a matrix, better shot-to-shot reproducibility, 
desorption properties, increase of signal/noise ratio, and increased stability under vacuum 
were observed. Herein, we report [OA][CHCA] as a matrix for the detection of 
hydrophobic and hydrophilic lipids, peptides, and proteins on tissue samples. Rat brain 
tissue sections were imaged to demonstrate the use of [OA][CHCA] in direct analysis of 
tissues. We evaluated shot-to-shot reproducibility, vacuum stability, homogeneity, and 
signal intensity in positive ion mode MS. In molecular imaging applications, 
[OA][CHCA] shows enhanced performance over DHB.  
4.2 Experimental 
4.2.1 Materials 
α-Cyano-4-hydroxycinmic acid (CHCA), oleylamine (OA), 2,5-dihydroxybanzoic 
acid (2,5-DHB), sinapinic acid (SA), methanol, [GLU1] Fibrino peptide B human, 
gramicidin, 2,5-dihydroxybenzoic acid (DHA), bacteriorhodopsin (BR) from 
Haloobacterium salinarum, acetonitrile (CH3CN), trifluoroacetic acid (TFA), and 
methanol were purchased from Sigma and used as received. MTP 384 massive target T 
was obtained from Bruker Daltonics. ITO coated conduction glass slides for MALDI 




4.2.2 Synthesis and Characterization of GUMBOS  
The GUMBOS matrix was prepared as in previous studies [34]. Briefly, 0.5 g of 
OA was dissolved in 10 mL of methanol to yield a 0.187 M solution. An equimolar 
amount of CHCA was prepared and dissolved in methanol. The CHCA solution was 
added to the OA solution and stirred for 24 hours. Methanol was removed using rotary 
evaporation. The melting point of [OA][CHCA] was determined using a melting point 
apparatus (Digit Melt MPA 160, Stanford Research Systems). 
4.2.3 NMR Analysis  
For 1H analysis of CHCA and [OA][CHCA] were dissolved in deuterated 
dimethyl sulfoxide-d6 (DMSO) (Figure 4.1). The red trace represents CHCA and the blue 
trace represents [OA][CHCA]. The carboxylic acid group on CHCA has a proton with a 
chemical shift around 11 ppm. The disappearance of this proton indicates the reaction 
between oleylamine and CHCA is complete. In addition to the NMR characterization, the 
compound was also characterized by electrospray ionization and this data is shown in 





Figure 4.1. 1H NMR for [OA][CHCA]. The red spectrum corresponds to CHCA while the 
blue corresponds to [OA][CHCA]. Disappearance of a peak at 11 ppm indicates a 
complete reaction. 
4.2.4 Tissue Preparation 
A rat was sacrificed by decapitation by Louisiana State University School of 
Veterinary Medicine (13-075) and immediately dissected to remove the brain. The rat 
brain section was covered with liquid nitrogen and foil to keep the sample below -80 °C 
in order to prevent protein and peptide degradation. Rat tissue sections of 10 µm were 
mounted on indium tin oxide (ITO) coated glass slides. The samples were used without 
washing and were stored at -80°C. Before being used in MALDI, the slides were stored 
in a desiccator for 15 minutes. These samples were then coated with matrix and 
transferred to stainless steel MALDI plates for imaging.  
4.2.5 Sample Preparation for MALDI TOF MS 
Matrix solutions were prepared fresh daily with CHCA at a concentration of 10 




[OA][CHCA] was dissolved in 1 mL of acetonitrile and H2O with 0.1% TFA in a ratio of 
2:1. The dried droplet method was used for sample preparation, in which 1 µL of the 
matrix and 1 µL of the analyte were mixed on the target. The sample was then allowed to 
dry at room temperature. For MALDI IMS analysis, both matrices DHB and 
[OA][CHCA], were dissolved in a mixture of methanol and water at a ratio of 70:30 and 
0.1% TFA. The concentration of both matrices was 20 mg DHB and 10 mg [OA][CHCA] 
in 1 mL of methanol and water with TFA mixture.  
4.2.6 MALDI-TOF MS  
IMS spectra were acquired using a MALDI-TOF mass spectrometer (Ultra 
fleXtreme, Bruker, Bremen, Germany) in positive ion reflectron mode. The ion 
acceleration potential was 25 kV with 500 laser shots. A frequency tripled Nd: YAG laser 
at a wavelength of 355 nm with a pulse duration of 3 ns was used for ionization. Data 
were processed using Flex Analysis 3.3 software (Bruker). 
4.3 Results and Discussion 
4.3.1  Characterization of [OA][CHCA] 
Oleylamine α-cyano-4-hydroxycinnamic acid, ([OA][CHCA]) was synthesized as 
described above at a 1:1 molar ratio in methanol. The cation, OA was used here to 
significantly enhance the solubility of hydrophobic peptides and proteins due to the long 
alkyl chain. [OA][CHCA] was characterized using 1H NMR (Figure 1). Disappearance of 
the carboxylic acid proton present in CHCA indicates that the reaction between OA and 






































The ultraviolet visible absorbance spectra of CHCA and [OA][CHCA] is shown in Figure 
2. Both compounds have a broad absorption from 380 to 260 nm (Figure 4.2). The 
absorbance maximum of the parent compound, CHCA, occurs at 330 nm, whereas the 
maximum of [OA][CHCA] is blue shifted to 328 nm. The molar absorptivity of CHCA is 
almost twice as large as that of the CHCA-based GUMBOS at a wavelength 355 nm, 
which was used for MS analysis (Table 4.1).  
 
Figure 4.2. Absorbance spectra of 50 µM solutions CHCA and [OA][CHCA] in 
methanol. 
	  
  Figure 4.3 shows the laser desorption ionization (LDI) mass spectrum for 
































for [OA][CHCA] are m/z 178 corresponding to [M- OA-CN+H]+, m/z 268 corresponding 
to [oleylamine]+, m/z 300 corresponding to [oleylamine + O2]+, and m/z 483 
corresponding to [OACHCA+H2O]+. Electrospray ionization was used to show the 
positive ion and negative ions, which resulted in m/z 268 and 189, respectively.  
Figure 4.3. Laser desorption ionization spectra of [OA][CHCA] matrix (no analyte present). 
4.3.2 GUMBOS as a MALDI Matrix for Detection of Peptides and Proteins 
We evaluated [OA][CHCA] as a matrix for MALDI analysis of hydrophilic 
peptides (angiotensin II, [GLU1] fibrinopeptide B) and the hydrophobic protein 
(bacteriarhodopsin). The primary reason oleylamine was chosen as the cation was to 
increase the hydrophobicity of CHCA and increase the interaction of the matrices with 
both hydrophobic and hydrophilic analytes. The synthesized GUMBOS was successfully 
used as matrices for MALDI. The hydrophobic tail of OA can increase the interaction of 
















MALDI. The CHCA head group is polar and can protonate the analyte making it a good 
matrix. [OA][CHCA] is not soluble in water, so methanol was used as the solvent. The 
dried droplet method was used for sample preparation because it is rapid and simple.  
First [OA][CHCA] was evaluated alone without analytes (Figure 4.3) as a control 
to determine the background signal of the matrix. Then, the selected proteins and 
peptides were evaluated with the matrices. Angiotensin II and [GLU1] Fibrinopeptide B 
showed clear signals at m/z 1046.54 and m/z 1570.57, respectively, which corresponds to 
the [M+H]+ peak. Bacteriorhodopsin showed a clear signal at m/z 26,225, which also 
corresponds to the [M+H]+ peak. MALDI spectra for angiotensin II and 
bacteriorhodopsin are shown in Figures 4.4 and 4.5. Figure 4.4 is a mass spectrum of 0.1 
fmol angiotensin II with [OA][CHCA] as a matrix. Figure 4.5 is the mass spectrum of the 
hydrophobic protein bacteriorhodopsin (BR) with [OA][CHCA] as a matrix. The results 
obtained using [OA][CHCA] and DHB as matrices to detect hydrophilic peptide [GLU1] 
Fibrinopeptide B at a concentration of 1 pmol is summarized in (Figure 4.6) and (see the 
appendix table 1 and Figure A9 and A10). The relative standard deviation (RSD) was 
calculated to determine spot-to-spot reproducibility. RSD was evaluated by calculating 
the average signal intensity at 12 different positions. Figure 4.6 reveals that improved 
spot to spot reproducibility was obtained and also [OA][CHCA] showed higher signal 
intensity than DHB. In addition, [OA][CHCA] was very stable under high vacuum and 
yields homogenous mixtures with hydrophobic peptides or proteins, thereby overcoming 





Figure 4.4. Mass spectrum reflectron mode of 0.1 fmol angiotensin II with [OA][CHCA] 
matrix and inside the spectra zoomed area.   
 

















Figure 4.6. Average MALDI of signal intensity for hydrophilic peptide GLU1 
Fibrinopeptide (1 pmol) with DHB and [OA][CHCA] matrices. 
	  
4.3.3 Direct Detection of Lipids in Rat Tissue 
Lipids are the most prevalent biomolecules in the brain where they are the major 
component after water. They are the building block of cellular membranes and energy 
storage units in the body; further, they aid in signal transduction for biological processes, 
playing an important role in immunology. Lipids interact with proteins and are studied 
for drug use.[12]. Imaging mass spectrometry (IMS) has been used to visualize and 
identify biomolecules on rat brain tissue. IMS of lipids can provide information about the 
identity of phospholipids (PLs) and spatial distribution of PLs on tissues. In order to 
study lipids in situ, we first had to optimize the tissue section thickness to give the best 
signal intensity. To do this we studied tissues ranging in thickness from 5 to 20 µm.  We 
found the best thickness was 10 µm of tissue, because that thickness gave the best signal 
























proper solvent was determined. [OA][CHCA] GUMBOS and DHB, a commonly 
employed matrix for detecting lipids on tissue, were used as matrices. Methanol and 
water with 0.1% TFA at a ratio of (70:30) was used as a solvent. Concentrations of 20 
mg/mL DHB and 10 mg/mL GUMBOS were used. The corresponding spectra comparing 
the two matrices were collected in positive ion mode and are shown in Figures 4.7 and 
4.8. [OA][CHCA] showed higher signal intensity compared to DHB. The m/z region 
between 734 and 820 showed high intensity for lipids. Some important phospholipids, 
such as, phophotidylcholine (PC) and sphingomyeline (SM), were detected with 
[OA][CHCA]. For example the following peaks were detected m/z 734.5(PC 32:0), m/z 
760.5 (PC 34:1), m/z 782.5 (PC 34:1 +Na), 788 (PC 36:1). Most of the peaks generated in 
positive mode are PC and SM because they are the major constituents of cell 
membranes.[24, 28] The most abundant species of phosphatidylcholine (PC) found in the 
spectra were 16:0/ 16:0 PC ([M+H]+ m/z 734.5, [M+Na]+ m/z 756.5, [M+ K]+ m/z 772.5), 
and 16:0/18:1 PC ([M+H]+ m/z 760.5, [M+Na]+ m/z 782.6, [M+K]+ m/z 798.6). 
Phospholipids detected by [OA][CHCA] showed two times higher intensity than when 
the matrix DHB was used. During imaging it was found that [OA][CHCA] is stable at 
high vacuum and improved the signal intensity for phospholipids on the rat brain tissue as 
compared with DHB. Identities of these species were confirmed by previous studies in 
the literature.[30, 35] The most abundant species of phosphatidylcholine (PC) found in the 
spectra were 16:0/ 16:0 PC ([M+H]+ m/z 734.5, [M+Na]+ m/z 756.5, [M+ K]+ m/z 772.5), 
and 16:0/18:1 PC ([M+H]+ m/z 760.5, [M+Na]+ m/z 782.6, [M+K]+ m/z 798.6). These 
phospholipids detected by [OA][CHCA] showed two times higher intensity than with 




identities of these species were confirmed by papers in the literature.[30, 35]  There are few 
peaks shown above m/z 1000. 
 
	  






































































Figure 4.8. MALDI spectrum obtained from a rat brain tissue in positive ionization mode. 
The tissue section was coated with GUMBOS [OA][CHCA]. Inset: Zoom from m/z 600 
to m/z 875. 
	  
Figure 4.9. Optical imaging: A) 10 µm thick rat brain tissue. B) Tissue coated with 




































































Microscopy was used to characterize the size of DHB and [OA][CHCA] crystals 
formed on the tissue sections. These images were taken by using a Zeiss steREO Lumar. 
Figure 4.9A shows a rat brain tissue section in the absence of a matrix coating. Rat brain 
tissue sections after coating with the matrices [OA][CHCA] and DHB are shown in 
Figures 4.9 B and 4.9 C, respectively. A nebulizer was used to spray the matrices on the 
tissue sections and approximately 3 mL of the matrix solution was used to cover the 
tissue. A flow rate of 100 µL/min was utilized and the distance between the tissue and 
nebulizer was around 12 cm. Morphology of the matrix is the most important factor for 
desorption and ionization of lipids. DHB has been shown to form large crystals (Figure 
4.9 C) and [OA][CHCA] was found to form smaller crystals as compared to DHB. The 
homogeneity of the matrix [OA][CHCA] on the sample is increased as compared to 
DHB, since [OA][CHCA] forms smaller crystals (Figure 4.9 B). Formation of smaller 
crystals provides an explanation for the higher signal intensity and better shot-to-shot 
reproducibility compared with DHB.[36] Matrices that formed smaller crystals were 
completely volatilized after irradiation by the laser. However, matrices that formed larger 
crystals were not completely volatilized after irradiation by the laser. It is also notable 
that [OA][CHCA] remained stable under vacuum through the duration of the imaging 
experiments. 
Phospholipids can be classified into different groups.[14] Thus, some 
phospholipids can be identified using positive ion mode, while others require negative 
ion mode. For some phospholipids, either mode can be used. Common phospholipids 
from tissues include phosphatidylcholine (PC), phosphatidylinositol (PI), phosphoric acid 




Normally, the peaks for these phospholipids appear between m/z 500 to 1000, with few 
above m/z 1000. They typically have low intensity and little fragmentation (Table 4.2).   
 
Table 4.2. 	  Detected m/z values corresponding to phospholipids in positive ion mode. 
Phospholipids ID M+H M+Na M+K 
PC24:3 616.17   
SM 16:0  724.898  
SM18:0 731.619   
PC32:1 734.594 756.566 772.55 
PC 34:1 760.575 782.557 798.528 
PC34:0 762.595 784.73  
PC36:1 788.615 810.604 826.565 
PC36:3  806.565 822.542 
PC36:4   820.512 
PC38:4  832.629 848.637 
PC40:6 834.627   
PC40:5 *   
PC40:4 838.773   
PC38:6   844.503 
PS36:1   850.67 
GlcCer 24:0 OH   866.711 
ST 38:4   868.487 
PC 32:0 (2M+H) 1468.104   
SM 16:0  724.898  
SM18:0 731.619   
PC32:1 734.594 756.566 772.55 
PC 34:1 760.575 782.557 798.528 
PC34:0 762.595 784.73  
PC36:1 788.615 810.604 826.565 
PC36:3  806.565 822.542 
PC36:4   820.512 
PC38:4  832.629 848.637 
PC40:6 834.627   
PC40:5 *   
PC40:4 838.773   
PC38:6   844.503 
PS36:1   850.67 
 
The heterogeneous distribution of several phospholipids in the brain tissue can be 




acquired with [OA][CHCA] as a matrix from rat brain tissue sections in positive ion 
mode. Figures 4.10 A-D display the different disruption of phospholipids such as PC 
32:OK (m/z 772.5), PS 36:1K (m/z 850.6), PC 36:1K (m/z 826.5). For example, m/z 772 
PC32:0K is found mostly in the caudate putamen and lateral ventricle regions of the 
brain; conversely, it is low in corpus callosum (Figure 4.10A). However, m/z 850 
PS36:1K is high in corpus callosum and is low in caudate putamen and lateral ventricle 
(Figure 4.10B). Furthermore, the use of MALDI IMS can distinguish the presence of two 
different phospholipids within the same tissue section (Figure 4.10D and 4.10E). The 
distribution of m/z 734 PC 32:0. m/z 734 PC 32:0 was primarily found in the cerebral 
cortex and lateral ventricle, whereas m/z 826.5 PC 36:1K was distributed throughout the 
corpus callosum (Figure 4.10D). From Figure 4.10F it is strongly suggested that both m/z 





Figure 4.10. [OA][CHCA] was as matrix for MALDI IMS for detecting different lipids 
on the rat brain tissue.A) m/z 772.5 PC 32:0K, (B) m/z 850.6 PS 36:1K, (C) Represent 
different distribution of two m/z 772.5 and PC 32:0K and m/z 550.6 PS 36:1K. (D) m/z 
734.5 PC 32:0, (E) 826.5 PC 36:1K on the rat of brain tissue. (F) Represent different 











[OA][CHCA] can also be used in negative mode to ionize the lipids. Figure 4.11 shows 
MALDI spectrum in negative mode for the detection of lipids on brain tissue. The highest 
peak is m/z 902 ST-OH 42:3.  
 
Figure 4.11. MALDI mass spectrum of rat brain tissue in negative ion reflectron mode 
with [OA][CHCA] matrix. 
	  
4.4  Conclusion  
In this study, we synthesized a novel matrix for the detection of phospholipids in 
both negative and positive ion mode. [OA][CHCA] was characterized with 1H NMR and 
ESI-MS. The matrix was tested using the peptides angiotensin II and GLU1 
fibrinopeptide standards. The results reveal that [OA][CHCA] shows higher signal 
intensity and RSD as compared with DHB. [OA][CHCA] was successful at detecting 



















Furthermore, [OA][CHCA] detected phospholipids directly on tissues in both negative 
and positive ion modes and was comparable with DHB. [OA][CHCA] surpassed DHB in 
several experiments by providing more homogenous deposition on tissue compared with 
DHB. Finally, [OA][CHCA] showed higher signal intensity and better reproducibility 
than the commonly used DHB, and was shown to be stable under vacuum.     
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CHAPTER 5: CONCLUSIONAND FUTURE DIRECTIONS 
5.1 Concluding Remarks   
The studies reported herein describe novel ionic liquid-based matrix compounds 
using 1-aminopyrene (AP) and AP-derived group of uniform materials based on organic 
salts (GUMBOS) for the analysis of peptides using MALDI MS. A number of solid phase 
salts, i.e. GUMBOS, were synthesized using AP as a cation and various anions to tune 
the hydrophobicity of the GUMBOS. The performance of these tunable GUMBOS as 
MALDI matrices for the analysis of hydrophobic and hydrophilic peptides was evaluated 
in terms of sensitivity and reproducibility in comparison to conventional matrix 
compounds. Detection of hydrophobic biomolecules remains an obstacle for analysis by 
MALDI. This stems from the fact that most matrices for MALDI are hydrophilic and 
therefore have low affinity for hydrophobic biomolecules. Herein, 1-aminopyrene (AP) 
and AP-based GUMBOS were investigated as MALDI matrices for hydrophobic 
peptides, and their performance was evaluated in terms of sensitivity and reproducibility. 
AP was selected for these studies because it exhibits strong absorption of appropriate 
laser radiation, as well as displaying hydrophobic characteristics and ability to protonate 
the analytes. In this study, we synthesized and tested a series of AP-based GUMBOS 
including [AP][chloride], [AP][ascorbate], and [AP][bis(trifluoromethane) sulfonamide] 
([AP][NTf2]). The relative hydrophobicity of these compounds and conventional MALDI 
matrices were estimated by measuring their 1-octanol/water partition coefficients (Ko/w), 
which indicated that these compounds could be made much more hydrophobic. The 
matrix compounds were then examined as MALDI matrices for analysis of hydrophobic 




hydrophobic peptides, these matrices provided enhanced sensitivity and better spot-to-
spot reproducibility as compared to the conventionally used matrix compounds. It was 
observed that these GUMBOS compounds tend to form small crystals on the MALDI 
target. These new classes of materials are promising matrices for effective detection of 
various biomolecules. A mixture of hydrophobic (valinomycin) and hydrophilic 
(angiotension II) peptides was analyzed using AP and AP-based GUMBOS and 
compared with conventional matrix compounds for peptides. The selectivity between 
these matrices was dependent on the hydrophobicity of the matrices. Increasing the 
hydrophobicity of the matrix increases the affinity to hydrophobic peptides. We observed 
that CHCA, [AP][Asc], and [AP][Cl], showed good affinity for hydrophilic peptides.  
Interaction of analytes with MALDI matrices that are composed of AP and AP-based 
GUMBOS was investigated using a hydrophobic (gramicidin) and a hydrophilic peptide 
(angiotensin II). Fluorescence anisotropy and Scatchard analysis were used to study and 
understand the interaction between matrices and peptides. Our results show strong 
binding of AP, a hydrophobic matrix, with gramicidin, a hydrophobic peptide and weak 
binding with angiotensin II, a hydrophilic peptide. Conversely, it appears that the 
hydrophilic matrix [AP][ascorbate] ([AP][Asc]), binds strongly with angiotensin II and 
demonstrates weaker binding with gramicidin. Thus, by changing the hydrophobicity of 
matrices we can tune the binding affinity of peptides. The binding results correlated well 
with MALDI MS results and were found to complement each other. It is important to 
synthesize new matrix materials for the analysis hydrophobic peptides. Hydrophobic AP 
and AP-based GUMBOS demonstrated stronger interaction and higher detection with a 




the hydrophilic peptide, angiotensin II, with higher signal intensity. This study presents a 
unique approach towards predicting matrix-analyte interactions in MALDI by use of 
fluorescence spectroscopic measurements and related analysis techniques. 
Herein we report the use of novel GUMBOS, oleylamine α-cyano-4-
hydroxycinnamic acid [OA][CHCA], as a matrix for MALDI IMS detection of lipids in 
tissue using nebulizer spray to apply GUMBOS. Direct tissue analysis with a GUMBOS 
matrix was compared with that of 2,5-dihydroxybenzoic acid (DHB), a common matrix 
used to image lipids. The use of [OA][CHCA] yielded higher signal intensity and 
enhanced spectral quality, including resolution and noise. Formation of smaller crystals, 
improved homogeneity of the matrix with tissue, and better signal reproducibility was 
also found when our system was compared with the conventional matrix 2,5-
dihydroxybenzoic acid (DHB). These enhancements were used to examine the 
distribution and localization of different classes of lipids in tissue.  
5.2 Future Work 
In ongoing work GUMBOS have been synthesized based on the conventional 
matrix for detecting hydrophobic and hydrophilic biomolecules directly on tissues such 
as the brain or kidney tissues of rats. Notably, GUMBOS matrices can be easily tuned, 
they give high homogeneity of crystals with analytes, and they have high sensitivity and 
selectivity. By adding various functional groups to the conventional matrix, the properties 
of the matrix can be changed in a way that will be helpful for detecting different peptides 
and proteins on tissues. They can be used as ions in the synthesis of GUMBOS matrices 
with varying hydrophobicity. Additionally, the use of binary matrices can be studied by 




and hydrophilic peptides simultaneously with the same signal intensity. The ratio of 
hydrophobic and hydrophilic matrices can also be varied to optimize peptide detection. In 
addition, we can study the mass spectra of tissues after the digestion of tissue to help to 
understand what kind of peptides or proteins are present.  
 The mechanism of the interaction of matrices with analytes, in general, remains 
unclear. In order to develop better MALDI matrices, more investigation is needed to 
understand the mechanism after we fire the laser into target to form the plume. In this 
dissertation we studied the interaction between peptides and the matrix using 
fluorescence anisotropy and Scatchard analysis when the matrix and analyte are in a 
solvent. However, we have not yet studied interactions between the matrix and analyte 
when they are crystallized on the glass slide. We can use fluorescence anisotropy and 
Scatchard analysis to see the effect of changing the concentration of matrix while keeping 
the analyte concentration constant as they are mixed on the slide. In addition, the mixture 
of hydrophobic and hydrophilic analytes has not yet been studied in the laser plume. Also 
the interaction between matrices and analyte after solvent evaporation can be studied 
using confocal microscopy, fluorescence and X-ray.  
Another direction we need to investigate is the use of GUMBOS in nanoparticle 
form (nanoGUMBOS) as matrices.  Variations in the hydrophobicity will change the size 
of the nanoGUMBOS; therefore, investigation of the properties of the matrix and its 
binding with proteins or peptides in correlation to the change in size of the 




APPENDIX A SUPPORTING INFORMATION 
 
Scatchard analysis was used to determine the type of binding and binding constants of 
hydrophobic and hydrophilic peptides with the MALDI matrices. The type of binding 
was determined based on the shape of the curve.  For example, a linear correlation 
between v/ (v/cf) correlates to specific binding. In addition, the correlation between v/ 
(v/cf) was also used to calculate specific binding constants. The Scatchard plots 
corresponding to these studies are shown in figures A1-A8.  
 
 
Figure A1: Scatchard plots of Ang II with AP 
 
 





































Figure A3: Scatchard plots of Ang II with  [AP][NTf2] 
 
 






































Figure A5: Scatchard plots of gramicidin with AP 
 
 





































Figure A7: Scatchard plots of gramicidin with [AP][NTf2] 
	  
	  
Figure A8: Scatchard plots of gramicidin with CHCA 
 
Table A1: Average MALDI Signal intensity for [Glu1]-fibrinopeptides B 
Matrices Average Intensity SDV RSD 
2,5-DHB 2550 3739 147 

































The spectra for the [Glu1]-Fibrinopeptides B protein is shown using DHB and [OA] 
[CHCA] as the respective matrices for figures A9 and A10. From the spectra it was found 
that [OA] [CHCA] gave a smaller relative standard deviation and higher signal intensity 
as compared to DHB.	  	  
	  
	  



























Figure A11. Positive and negative mode of ESI shows the formation of [OA] [CHCA]- 
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